Naked Brand (NAKD) 10-K 29 Apr 16 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jan. 31, 2016	Apr. 28, 2016	Jul. 31, 2015
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jan. 31, 2016
Trading Symbol	nakd
Entity Registrant Name	NAKED BRAND GROUP INC.
Entity Central Index Key	1,383,097
Current Fiscal Year End Date	--07-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		6,069,982
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Public Float			$ 4,953,158
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jan. 31, 2016	Jan. 31, 2015
Current assets
Cash	$ 4,780,994	$ 1,943,235
Accounts receivable, net of allowances of $64,998 (2015: $7,761)	127,422	99,145
Inventory, net	921,449	183,226
Prepaid expenses and deposits	956,807	383,651
Total current assets	6,786,672	2,609,257
Equipment, net	13,215	21,141
Intangible assets, net	73,095	44,156
Deferred costs	15,058	43,422
TOTAL ASSETS	6,888,040	2,717,976
Current liabilities
Accounts payable and accrued liabilities	993,399	299,887
Interest payable	6,025	62,650
Factored line of credit	527,711	0
Promissory notes payable	3,450	3,450
Current portion of convertible promissory notes	600,000	0
Total current liabilities	2,130,585	365,987
Deferred compensation	170,369	170,369
Convertible promissory notes	0	605,850
Derivative financial instruments	0	3,799,950
TOTAL LIABILITIES	2,300,954	4,942,156
STOCKHOLDERS' EQUITY (CAPITAL DEFICIT)
Common stock Authorized 11,250,000 common shares, par value $0.001 per share Issued and outstanding 6,069,982 common shares (2015: 1,010,391)	6,070	1,011
Common stock to be issued	15,000	15,000
Accumulated paid-in capital	50,953,341	25,083,735
Accumulated deficit	(46,381,080)	(27,317,681)
Accumulated other comprehensive loss	(6,245)	(6,245)
Total stockholders' equity (capital deficit)	4,587,086	(2,224,180)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (CAPITAL DEFICIT)	$ 6,888,040	$ 2,717,976

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Jan. 31, 2016	Jan. 31, 2015
Allowance for Doubtful Accounts Receivable, Current	$ 64,998	$ 7,761
Common Stock, Shares Authorized	11,250,000	11,250,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	6,069,982	1,010,391
Common Stock, Shares, Outstanding	6,069,982	1,010,391

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jan. 31, 2016	Jan. 31, 2015
Net sales	$ 1,389,414	$ 557,212
Cost of sales	1,291,219	800,695
Gross profit (loss)	98,195	(243,483)
Operating Expenses
General and administrative expenses	11,726,989	6,690,553
Foreign exchange	9,225	26,323
Total operating expenses	11,736,214	6,716,876
Operating loss	(11,638,019)	(6,960,359)
Other income (expense)
Interest expense	(878,934)	(465,618)
Accretion of debt discounts and finance charges	(7,255,346)	(2,425,697)
Derivative expense	0	(12,028,383)
Gain (loss) on extinguishment of debt	0	(810,765)
Debt conversion expense	0	(309,011)
Fair value mark-to-market adjustments	708,900	1,921,568
Total other income (expense)	(7,425,380)	(14,117,906)
Net loss for the period	$ (19,063,399)	$ (21,078,265)
Net loss per share
Basic	$ (10.13)	$ (23.33)
Diluted	$ (10.13)	$ (23.33)
Weighted average shares outstanding
Basic	1,881,901	903,659
Diluted	1,881,901	903,659

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders Equity (Capital Deficit) - USD ($)	Common Stock [Member]	Accumulated Paid-In Capital [Member]	Common stock to be issued [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]	Total
Beginning Balance at Jan. 31, 2014	$ 868	$ 4,907,955	$ 7,500	$ (6,239,416)	$ (6,245)	$ (1,329,338)
Beginning Balance (Shares) at Jan. 31, 2014	868,204
Shares issued in connection with promissory notes	$ 1	2,749				2,750
Shares issued in connection with promissory notes (Shares)	1,000
Modification of convertible debt terms and warrants		697,400				697,400
Return to treasury pursuant to private placement escrow agreement	$ (15)	15
Return to treasury pursuant to private placement escrow agreement (Shares)	(15,000)
Shares issued pursuant the conversion of debt	$ 47	139,953				140,000
Shares issued pursuant the conversion of debt (Shares)	46,667
Shares issued in settlement of debt	$ 55	539,254				539,309
Shares issued in settlement of debt (Shares)	55,145
Shares issued in exchange for services rendered	$ 6	32,394	7,500			39,900
Shares issued in exchange for services rendered (Shares)	5,625
Shares issued as payment for interest owing under convertible debt arrangements	$ 49	274,774				274,823
Shares issued as payment for interest owing under convertible debt arrangements (Shares)	48,750
Derivative liability reclassifications		15,171,000				15,171,000
Stock based compensation		3,318,241				3,318,241
Net loss for the year				(21,078,265)		(21,078,265)
Ending Balance at Jan. 31, 2015	$ 1,011	25,083,735	15,000	(27,317,681)	(6,245)	(2,224,180)
Ending Balance (Shares) at Jan. 31, 2015	1,010,391
Shares issued pursuant the conversion of debt	$ 79	236,985				237,064
Shares issued pursuant the conversion of debt (Shares)	79,025
Shares issued in exchange for services rendered	$ 2	11,998				12,000
Shares issued in exchange for services rendered (Shares)	2,500
Shares issued as payment for interest owing under convertible debt arrangements	$ 183	774,964				775,147
Shares issued as payment for interest owing under convertible debt arrangements (Shares)	183,205
Shares issued pursuant to the exercise of amended warrants	$ 586	2,342,243				2,342,829
Shares issued pursuant to the exercise of amended warrants (Shares)	585,705
Less: commissions paid		(91,422)				(91,422)
Shares issued in a public offering	$ 1,875	7,498,125				7,500,000
Shares issued in a public offering (Shares)	1,875,000
Less: share issue costs		(623,720)				(623,720)
Shares issued upon automatic conversion of debentures	$ 2,312	6,934,138				6,936,450
Shares issued upon automatic conversion of debentures (Shares)	2,312,150
Rounding shares issued in connection with reverse stock split	$ 22	(22)
Rounding shares issued in connection with reverse stock split (shares)	22,006
Derivative liability reclassifications		3,091,050				3,091,050
Stock based compensation		5,632,267				5,632,267
Modification of warrants		63,000				63,000
Net loss for the year				(19,063,399)		(19,063,399)
Ending Balance at Jan. 31, 2016	$ 6,070	$ 50,953,341	$ 15,000	$ (46,381,080)	$ (6,245)	$ 4,587,086
Ending Balance (Shares) at Jan. 31, 2016	6,069,982

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jan. 31, 2016	Jan. 31, 2015
Cash flows from operating activities
Net loss for the year	$ (19,063,399)	$ (21,078,265)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	26,877	2,109
Provision for obsolete inventory	211,000	179,000
Depreciation and amortization	17,420	29,858
Other non cash items (Schedule 1)	12,178,713	17,333,256
Unrealized foreign exchange	0	2,760
Finance fees paid in connection with debt extinguishment	0	(38,008)
Changes in operating assets and liabilities:
Accounts receivable	(55,154)	(32,395)
Advances receivable	0	50,000
Prepaid expenses and deposits	(573,156)	(312,985)
Inventory	(949,223)	241,820
Accounts payable	705,485	(312,499)
Interest payable	722,231	62,650
Deferred compensation	0	170,369
Net cash used in operating activities	(6,779,206)	(3,702,330)
Cash flows from investing activities
Acquisition of intangible assets	(33,314)	(27,549)
Purchase of equipment	(5,119)	(21,429)
Net cash used in investing activities	(38,433)	(48,978)
Cash flows from financing activities
Proceeds from share issuances	9,842,829	0
Share issuance offering costs	(715,142)	0
Proceeds from the issuance of promissory notes	0	927,168
Repayments of promissory notes	0	(413,385)
Proceeds from convertible promissory notes	0	6,094,100
Repayments of convertible promissory notes	0	(364,640)
Debt offering costs	0	(616,178)
Repayments on factoring arrangements	(732,289)	0
Advances under factoring arrangements	1,260,000	0
Net cash provided by financing activities	9,655,398	5,627,065
Net increase in cash	2,837,759	1,875,757
Cash at beginning of the year	1,943,235	67,478
Cash at end of the year	4,780,994	1,943,235
Cash paid during the year for:
Interest	125,140	112,251
Income Taxes	0	0
Non-cash financing activities:
Extinguishment of accounts payable with equity	12,000	11,158
Settlement of notes through the issuance of shares	0	225,308
Reclassification of derivative liability to additional paid in capital	3,091,050	0
Conversion of convertible debt to shares	7,169,809	0
Interest paid in shares	778,856	0
Profit and loss items not involving cash consists of:
Shares to be issued in exchange for services	0	39,900
Finance charge in connection with modification of warrant terms	63,000	0
Loss on extinguishment of debt	0	810,765
Stock based compensation	5,632,267	3,318,241
Derivative expense	0	12,028,383
Change in fair value of derivative financial instruments	(708,900)	(1,921,568)
Debt issuance costs paid in warrants	0	1,552,700
Debt conversion expense	0	309,011
Amortization of deferred financing fees	28,364	674,069
Interest capitalized to convertible debt	0	10,372
Shares issued as penalty under debt agreements	0	1,250
Interest paid in kind	0	274,823
Accretion of debt discount	7,163,982	235,310
Total Other items not involving Cash	$ 12,178,713	$ 17,333,256

Nature of Business

Nature of Business	12 Months Ended
	Jan. 31, 2016
Nature of Business [Text Block]	1. Nature of Business Naked Brand Group Inc. (the “Company”) is a manufacturer and seller of direct and wholesale men’s and women’s undergarments and intimate apparel in the United States and Canada to consumers and retailers through its wholly owned subsidiary, Naked Inc. (“Naked”). The Company currently operates out of New York, United States of America. Effective August 10, 2015, the Company effected a reverse stock split of its common stock on the basis of 1:40. As such, the Company’s authorized capital was decreased from 450,000,000 shares of common stock to 11,250,000 shares of common stock and an aggregate of 53,278,818 shares of common stock issued and outstanding were decreased to 1,331,977 shares of common stock. These financial statements give retroactive effect to such reverse stock split and all share and per share amounts have been adjusted accordingly.

Ability to Continue as a Going

Ability to Continue as a Going Concern	12 Months Ended
	Jan. 31, 2016
Ability to Continue as a Going Concern [Text Block]	2. Ability to Continue as a Going Concern These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) on a going concern basis, which assumes that the Company will continue to realize its assets and discharge its obligations and commitments in the normal course of operations. Realization values may be substantially different from carrying values as shown and these consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of January 31, 2016, the Company had not yet achieved profitable operations, had incurred a net loss of $19,063,399 and had an accumulated deficit of $46,381,080 and expects to incur significant further losses in the development of its business, which casts substantial doubt about the Company’s ability to continue as a going concern. To remain a going concern, the Company will be required to obtain the necessary financing to pursue its plan of operation. Management plans to obtain the necessary financing through the issuance of equity and/or debt. Should the Company not be able to obtain this financing, it may need to substantially scale back operations or cease business. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2016
Summary of Significant Accounting Policies [Text Block]	3. Summary of Significant Accounting Policies Principles of Consolidation and Basis of Accounting These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Naked. All inter-company transactions and balances have been eliminated. Reporting Currency and Foreign Currency The functional currency of the Company is the US dollar. Transaction amounts denominated in foreign currencies are translated into their US dollar equivalents at exchange rates prevailing at the transaction dates. Financial instruments denominated in foreign currencies are revalued each period at exchange rates prevailing at each balance sheet date until settled. Foreign currency gains and losses on transactions or settlements are recognized in the consolidated statement of operations. These consolidated financial statements have been presented in US dollars, which is the Company’s reporting currency. Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with GAAP in the United States of America. Segment Reporting The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. The Company’s chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. Accordingly, the Company has determined that as of January 31, 2016 and 2015, there is only a single reportable operating segment. The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. Revenues from external customers are all derived from customers located within North America as follows: 2016 2015 United States $ 1,090,024 $ 343,769 Canada 299,390 213,443 $ 1,389,414 $ 557,212 At January 31, 2016, the net book value of long-lived assets all located within North America were as follows: 2016 2015 Equipment Intangible assets Equipment Intangible assets United States $ 7,091 $ 53,738 $ 12,688 $ 14,211 Canada 6,124 19,357 8,453 29,945 $ 13,215 $ 73,095 $ 21,141 $ 44,156 Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts Sales are recorded when title and risk of loss has passed to the customer, when persuasive evidence of a sales arrangement exists, the selling price is fixed and determinable and collectability is reasonable assured. Accounts receivable consist of amounts due from customers and are recorded upon the sale of product to customers. Credit terms are extended to customers in the normal course of business and no collateral is required. The Company estimates an allowance for doubtful accounts based on historical losses, the existing economic conditions and the financial stability of its customers. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received. Inventory Inventory is stated at the lower of cost or market value. Cost is determined using the weighted average method, which under the circumstances, management believes will provide for the most practical basis for the measurement of periodic income. Management periodically reviews inventory for slow moving or obsolete items and considers realizability based on the Company’s marketing strategies and sales forecasts to determine if an allowance is necessary. If market value is below cost then an allowance is created to adjust the carrying amount of inventory. Equipment Equipment is recorded at cost. Equipment is depreciated using the straight-line method over the estimated useful lives. The estimated useful lives for each asset group are as follows: Years Furniture and equipment 5 Computer equipment 2 At the time depreciable property is retired or otherwise disposed of the related cost and accumulated depreciation is removed from the accounts and any resulting gain or loss is reflected in the consolidated statement of operations. Intangible Assets Indefinite-life intangible assets, consisting of costs to acquire trademarks with an indefinite life, are recorded at cost, net of impairment charges, if applicable. No amortization has been taken on indefinite life intangible assets. Indefinite-life intangible assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Website Costs The Company recognizes the costs associated with developing a website in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 350–40, Website development costs Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred to develop internal–use computer software during the application development stage are capitalized. Training costs are not internal–use software development costs and, if incurred during this stage, are expensed as incurred. These capitalized costs are amortized based on their estimated useful life over two years. Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the related carry amounts may not be recoverable. Such a review involves assessing qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that a long-lived asset is impaired. If the Company assesses that there is a likelihood of impairment, then the Company will perform a quantitative analysis comparing the carrying value of the assets with the estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize an impairment loss at that date for the amount by which the carrying amount of the asset exceeds its fair value. Management has determined that no impairment has been identified in the years ended January 31, 2016 or 2015. Shipping and Handling Costs Costs associated with the Company’s third-party shipping, warehousing and handling activities are included within operating expenses on the consolidated statements of operations. (i) Shipping costs associated with marketing related promotions are included as a component of general and administrative expenses. These shipping costs were $10,440 for the year ended January 31, 2016 ($25,930 for the year ended January 31, 2015). (ii) Shipping costs billed to customers are recorded as revenues and related out-bound shipping costs incurred by the Company are recorded as cost of sales. (iii) Warehousing and handling costs, and shipping costs associated with transfers of inventory to and from third party warehouses to the Company’s warehouse are included in general and administrative expense as warehouse management. These warehousing, shipping and handling costs were $404,092 for the year ended January 31, 2016 ($91,000 for the year ended January 31, 2015). Advertising Expense The Company expenses advertising costs to operations during the period in which they are incurred. The Company expensed $201,198 and $38,278 related to advertising for the years ended January 31, 2016 and 2015, respectively. Income Taxes The current income tax represents the amount of income taxes expected to be paid or the benefit expected to be received for the current year taxable income or loss. Deferred income taxes are recognized for the future tax consequences of temporary differences arising between the carrying value of assets and liabilities for financial statement and tax reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the recoverability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers projected future taxable income and tax planning strategies in making this assessment. The Company recognizes the impact of a tax position in the consolidated financial statements if the position is more likely than not to be sustained upon examination on the technical merits of the position. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits and penalties as income tax expense. The Company has no uncertain tax positions as of January 31, 2016 and 2015, respectively; consequently, no interest or penalties have been accrued by the Company. Fair Value of Financial Instruments The Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, Fair Value Measurements and Disclosures Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The Company’s financial instruments consist of cash, accounts receivable, accounts payable, notes payable, related party payables and convertible promissory notes. Other than convertible promissory notes, the fair values of these financial instruments approximate their respective carrying values because of the short maturity of these instruments. The Company determined that the aggregate fair value of promissory notes payable outstanding at January 31, 2016 and 2015, based on Level 2 inputs in the fair value hierarchy, was equal to their aggregate book value based on the short maturities and current borrowing rates available to the Company. The fair value of the Company’s convertible promissory notes is based on Level 3 inputs in the fair value hierarchy. The Company calculated the fair value of these notes by discounting future cash flows using rates representative of current borrowing rates for debt instruments without a conversion feature and by using the Black Scholes option pricing model to determine the fair value of the conversion feature using the following assumptions: 2016 2015 Risk-free interest rate 0.33% 0.61% Expected life (years) 0.67 2.34 Expected volatility (1) 91.47% 147.42% Stock price $2.79 $4.80 Dividend yields 0.00% 0.00% (1) The Company determined that the fair value of the convertible promissory notes at January 31, 2016 was $567,776 (2015: $15,476,300) based on a market interest rate of 18%. Debt issuance costs The Company incurs costs in connection with debt issuances, such as commissions and professional fees. Debt issuance costs are initially recorded as deferred financing expense on the consolidated balance sheets, and are amortized to financing expense over the term of the respective borrowings using the effective interest method. Any costs incurred or paid to the lender in connection with the issuance of debt represent a reduction in the proceeds received by the Company. The resulting discount is amortized as accretion expense over the term of the debt using the effective interest method. Derivative Financial Instruments The Company evaluates stock options, stock warrants and other contracts to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for under the relevant sections of ASC 815-40, Derivative Instruments and Hedging: Contracts in Entity’s Own Equity (“ASC 815”). Certain of the Company’s embedded conversion features on debt and outstanding warrants are treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to settle these outstanding contracts, or due to other rights connected with these contracts, such as registration rights. In the case of insufficient authorized share capital available to fully settle outstanding contracts, the Company utilizes the latest inception date sequencing method to reclassify outstanding contracts as derivative instruments. These contracts are recognized currently in earnings until such time as the warrants are exercised, expire, the related rights have been waived and/or the authorized share capital has been amended to accommodate settlement of these contracts. These instruments do not trade in an active securities market. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company estimates the fair value of these instruments using the binomial option pricing model. This model uses Level 3 inputs in the fair value hierarchy established by ASC 820 . Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. The most significant estimates made by the Company are those relating to uncollectible receivables, inventory valuation and obsolescence, product returns, and derivative valuations. Loss per share Earnings or loss per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted EPS is computed by dividing net income (loss) by the weighted-average of all potentially dilutive shares of common stock that were outstanding during the periods presented. The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants, would be used to purchase common stock at the average market price for the period. EPS for convertible debt is calculated under the “if-converted” method. Under the if converted method, EPS is calculated as the more dilutive of EPS (i) including all interest (both cash interest and non-cash discount amortization) and excluding all shares underlying the convertible debt or; (ii) excluding all interest and costs directly related to the convertible debt (both cash interest and non-cash discount amortization) and including all shares underlying the convertible debt. For the years ended January 31, 2016 and 2015, diluted EPS was calculated by including interest expense related to the convertible debt and excluding the shares underlying the convertible debt. Net loss per share was determined as follows: 2016 2015 Numerator Net loss $ (19,063,399 ) $ (21,078,265 ) Denominator Weighted average shares outstanding 1,881,901 903,659 Effect of dilutive securities Warrants and options - - Convertible debt - - Diluted weighted average shares outstanding 1,881,901 903,659 Basic net loss per share $ (10.13 ) $ (23.33 ) Diluted net loss per share $ (10.13 ) $ (23.33 ) Anti-dilutive securities not included in diluted loss per share relating to: Warrants and options outstanding 3,836,472 3,423,399 Convertible debt 60,000 2,449,944 3,896,472 5,873,343 Accounting for Stock-Based Compensation ASC Topic 718, Compensation – Stock Compensation The Company accounts for the granting of equity based awards to employees using the fair value method whereby all awards to employees will be recorded at fair value on the date of the grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. Compensation costs for stock-based payments to employees with graded vesting are recognized on a straight-line basis. The amount of cumulated compensation expense recognized at any date must at least equal the portion of the grant date value of the award that is vested at that date. Based on guidance in ASC 505-50, stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically remeasured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for stock-based payments with graded vesting are recognized on a straight-line basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term. New Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB, which are adopted by the Company as of the specified date. Unless otherwise discussed, management believes the impact of recently issued standards, which are not yet effective, will not have a material impact on our consolidated financial statements upon adoption. In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, "Revenue from Contracts with Customers". The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The premise of the guidance is that a Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 can be adopted by the Company either retrospectively or as a cumulative-effect adjustment as of the date of adoption. On April 1, 2015, the FASB decided to defer the effective date of the new revenue standard by one year. As a result, public entities would apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The Company has not yet evaluated the impact of the adoption of this new standard. In June 2014, the FASB issued ASU No. 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 will explicitly require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In April 2015, the FASB, issued the Accounting Standards Update 2015-03, Interest - Imputation of Interest (Subtopic 835-30) - Simplifying the Presentation of Debt Issuance Costs, that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. For public business entities, the final guidance will be effective for fiscal years beginning after December 15, 2015, however, early adoption (including in interim periods) is permitted. Upon adoption, an entity must apply the new guidance retrospectively to all prior periods presented in the financial statements. An entity is also required in the year of adoption to provide certain disclosures about the change in accounting principle, including the nature of and reason for the change, the transition method, a description of the prior-period information that has been retrospectively adjusted and the effect of the change on the financial statement line items (that is, debt issuance cost asset and the debt liability). The Company plans to adopt this standard beginning February 1, 2016. Adoption of this standard will result in the reclassification of $15,058 in deferred financing costs at January 31, 2016 from assets to a deduction from the related debt liability. In November 2015, the FASB issued Accounting Standards Update No. 2015-17 “Income Taxes: Balance Sheet Classification of Deferred Taxes (“ASU 2015-17”). ASU 2015-17 eliminates the requirement to bifurcate deferred taxes between current and non-current on the balance sheet and requires that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. ASU 2015-17 is effective for public entities in fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. The amendments for ASU-2015-17 can be applied retrospectively or prospectively and early adoption is permitted. The adoption of this standard is not expected to have a material impact for any period presented. In February 2016, FASB issued ASU 2016-02, Leases

Inventory

Inventory	12 Months Ended
	Jan. 31, 2016
Inventory [Text Block]	4. Inventory Inventory of the Company consisted of the following: 2016 2015 Finished goods $ 1,308,442 $ 362,226 Raw material 3,007 - 1,311,449 362,226 Less: allowance for obsolete inventory (390,000 ) (179,000 ) Total inventory $ 921,449 $ 183,226 Balances at January 31, 2016 and 2015 are recorded at historical cost, less amounts for potential declines in value. At January 31, 2016, management has recorded an allowance for obsolescence of $390,000 (2015: $179,000) to reduce inventory to its estimated net realizable value.

Equipment

Equipment	12 Months Ended
	Jan. 31, 2016
Equipment [Text Block]	5. Equipment Equipment of the Company consisted of the following at January 31, 2016 and January 31, 2015: 2016 2015 Furniture & equipment $ 10,250 $ 11,630 Computer equipment 26,082 20,963 36,332 32,593 Less: Accumulated depreciation (23,117 ) (11,452 ) $ 13,215 $ 21,141 Depreciation expense for the year ended January 31, 2016 was $13,047 (2015: $6,588). Intangible Assets Intangible assets of the Company consisted of the following at January 31, 2016 and 2015: Useful life 2016 2015 (Years) Trade Names/Trademarks $ 73,095 $ 39,781 Indefinite Website 49,512 49,512 2 122,607 89,293 Less: accumulated amortization (49,512 ) (45,137 ) $ 73,095 $ 44,156 Amortization expense for the year ended January 31, 2016 was $4,375 (2015: $23,270).

Related Party Transactions and

Related Party Transactions and Balances	12 Months Ended
	Jan. 31, 2016
Related Party Transactions and Balances [Text Block]	6. Related Party Transactions and Balances Related Party Balances At January 31, 2016, included in accounts payable and accrued liabilities is $43,089 (2015: $17,060) owing to directors and officers of the Company for reimbursable expenses and unpaid fees. These amounts are unsecured, non-interest bearing with no specific terms of repayment. At January 31, 2016, an amount of $Nil (2015: $978,779) in principal amounts of convertible notes payable and $Nil (2015: $8,247) in accrued interest payable, was owing to directors and officers of the Company. Included in convertible notes payable at January 31, 2016 is an amount of $Nil (2015: $791) in respect of these amounts owing, after applicable unamortized debt discounts. Related party transactions During the year ended January 31, 2016, included in general and administrative expenses is $Nil (2015: $58,400) in respect of directors fees and investor relations fees, $5,334,266 (2015: $3,147,400) in respect of share based compensation expense for the vesting of stock options granted to directors and officers of the Company, and $282,277 (2015: $132,500) in respect of marketing fees, of which $90,777 (2015: $Nil) was related to third party pass through costs, paid to a firm of which a direct family member of a director and officer of the Company is a principal. Pursuant to a board agreement dated September 24, 2013, the Company agreed to issue 1,875 shares of common stock every three months over the term of the one-year contract in connection with the appointment of a director of the Company, for an aggregate of 7,500 shares of common stock over the term. During the year ended January 31, 2016, the Company recorded directors’ fees of $Nil (2015: $24,900) in respect of common stock earned under this agreement. The fair values per share were determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. Effective June 10, 2014, the Company entered into an employment agreement with the Chief Executive Officer and director (the “CEO”) of the Company for a term of three years whereby (a) the CEO shall be entitled to a base salary of $400,000 per year, provided the CEO will forgo the first twelve months of the base salary and only receive minimum wage during that period; (b) the CEO received a sign-on stock option grant to purchase 1,428,750 shares of common stock of the Company, equal to 20% of the issued and outstanding shares of common stock of the Company on a fully-diluted basis, (the “CEO Options”), with each option exercisable at $5.12 per share and vesting in equal monthly instalments over a period of three years from the date of grant; and (c) the CEO will be eligible to receive an annual cash bonus for each whole or partial year during the employment term payable based on the achievement of one or more performance goals established annually by the Company’s board of directors. In connection with this employment agreement, the Company has agreed to issue 2,500 shares of common stock to a consultant of the Company. An amount of $15,000 is included in common stock to be issued at January 31, 2016 in respect of these 2,500 shares. The fair value of $4.80 per share was determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. At January 31, 2016, an amount of $170,369 (2015: $170,369) in deferred compensation related to the amortization of total base salary compensation due under this employment agreement, which is being amortized on a straight line basis over the term of the employment agreement. During the year ended January 31, 2016, the CEO received minimum wage compensation of $16,640 (2015: $10,400) under the terms of this employment agreement. On June 10, 2015, the CEO became eligible to receive her full base salary pursuant to the terms of her employment agreement, however, such base salary has not yet been paid as of January 31, 2016. The Company has accrued her base salary compensation payable and at January 31, 2016, an amount of $266,664 (2015: $Nil) is included in accounts payable and accrued liabilities in respect of such base salary payable. The CEO has agreed to allow the Company to defer payment of her salary provided such amounts accrue interest at a rate of 3% per annum. The Company is currently negotiating settlement of this base salary payable with the CEO. Effective June 9, 2014, the Company entered into an employment agreement with the Chief Financial Officer (the “CFO”) of the Company for a term of four years whereby (a) the CFO shall be entitled to a base salary of $200,000 per year; and (b) the CFO received a sign-on stock option grant to purchase 70,000 shares of common stock of the Company (the “CFO Options”), with each option exercisable at $5.12 per share and vesting annually over a period of four years from the date of grant. Subsequent to January 31, 2016, the CFO retired and as such, his employment agreement was terminated. Pursuant to the termination of this agreement, the Company entered into a separation agreement whereby the CFO will receive (i) severance payment equal to one hundred thousand dollars ($100,000), which is the equivalent of six (6) months of severance pay, payable in equal monthly installments and (ii) a payment equal to accrued and unused vacation time through the date of his retirement. Additionally, the unvested CFO Options were immediately forfeited on the date of his retirement and any vested CFO Options will be exercisable until ninety (90) days after the date of his retirement, at which time the vested CFO options will also expire. Effective June 23, 2014, the Company entered into an employment agreement with an officer (the “Officer”) of the Company for a term of four years whereby (a) the Officer shall be entitled to a base salary of $175,000 per year; and (b) the Officer received a sign-on stock option grant to purchase 92,500 shares of common stock of the Company, with each option exercisable at $5.12 per share and vesting annually over a period of four years from the date of grant.

Factoring Line of Credit

Factoring Line of Credit	12 Months Ended
	Jan. 31, 2016
Factoring Line of Credit [Text Block]	7. Factoring Line of Credit On June 11, 2015, the Company entered into a factoring agreement (the “Factoring Agreement”) with Capital Business Credit LLC (the “Factor”) whereby the Company may borrow the lesser of (i) $750,000 or (ii) the sum of up to 80% of trade receivables, 60% of finished goods inventory and 100% of any accepted side collateral, under the terms and conditions as outlined in the Factoring Agreement. A director and officer of the Company has provided side collateral of $500,000 to support a portion of the borrowings and has guaranteed repayment of the Company's indebtedness and performance of its obligations under the Factoring Agreement. The facility is secured by a general security interest over all of the Company assets and interests. The term of the agreement is for a period of one year and will automatically renew for additional one year terms, unless terminated at any time by the Factor or by the Company prior to such renewal, with thirty days’ prior written notice. Under the terms of the Factoring Agreement, the Company may sell and assign eligible accounts receivable to the Factor in exchange for advances made to the Company. The Factor purchases eligible accounts receivable net of a factoring commission of 0.9% of such receivable. The Company bears the risk of credit loss on the receivable, except where the Factor has provided credit approval in writing on such receivable. These receivables are accounted for as a secured borrowing arrangement and not a sale of financial assets. The facility bears interest on the daily net balance of any moneys owed at a rate of the greater of (i) 5.5% per annum; and (ii) 2% above the Prime Rate as quoted in the Wall Street Journal (the “Prime Rate”). At January 31, 2016, the Prime Rate was 3.25%, thus the facility was bearing interest at 5.5% . To the extent that net advances owing exceed the borrowing base described above, additional interest of 1% per annum shall be charged based upon the daily balance of any such over advance. Factor expenses and interest charged to operations during the year ended January 31, 2016 were $35,582 (2015: $Nil). At January 31, 2016, an amount of $527,711 (2015: $Nil) was owing under the terms of the Factoring Agreement, for advances made to the Company, net of repayments of such advances through the collection of factored receivables.

Promissory Notes Payable

Promissory Notes Payable	12 Months Ended
	Jan. 31, 2016
Promissory Notes Payable [Text Block]	8. Promissory Notes Payable (i) On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$28,750. The Company received $24,467 (CDN$25,000) in respect of this note, after an original issue discount (“OID”) of 15%, or $3,670 (CDN$3,750). The principal amount, net of the OID, matured and was repaid during the year ended January 31, 2015. At January 31, 2016, an amount of $3,450 (CDN$3,750) (2015: $3,450 (CDN$3,750)) is outstanding relating to the OID, which is repayable upon the Company reporting net income from operations in any single month. During the year ended January 31, 2015, the Company recorded accretion expense of $3,280 (2014: $Nil) in respect of the accretion of the discount on this note. (ii) On April 7, 2014, the Company entered into a securities purchase agreement with certain purchasers pursuant to which the Company agreed to issue 6% Senior Secured Convertible Promissory Notes (the “SPA Notes”) in the aggregate principal amount of $1,083,797. As consideration, the Company (i) received cash proceeds equal to $878,704 ; (ii) exchanged a promissory note with an outstanding amount of $76,388, being the principal and accrued interest due under a convertible promissory note dated December 24, 2013 for the issuance of a SPA Note in the same amount; and (iii) exchanged a promissory note with an outstanding amount of $128,705, being the remaining principal amount due under a convertible promissory note dated October 2, 2013 for the issuance of a SPA Note in the same amount. Repayment of the SPA Notes was collateralized against all the tangible and intangible assets of the Company. The principal amount of $1,083,797 was to mature on April 7, 2015 (the “Maturity Date”) and was bearing interest at the rate of 6% per annum, payable on the Maturity Date. On June 10, 2014, these notes, along with accrued interest of $10,362 were exchanged for securities in a subsequent offering (Note 9(i)), at an exchange rate equal to 90% of the price paid by investors in that offering. During the year ended January 31, 2015, the Company recorded debt conversion expense of $121,573, related to this purchase price discount upon these Notes being converted for units in the subsequent offering. The Company incurred $89,849 in issuance costs in respect of the SPA Notes. During the year ended January 31, 2016, the Company recorded $Nil (2015: $10,372) in respect of interest on the SPA Notes and $Nil (2015: $89,849) in respect of the accretion of deferred financing fees on the SPA Notes. (iii) During the year ended January 31, 2014, the Company received $75,000 in respect of a promissory note in the principal amount of $75,000. The promissory note matured on February 1, 2014 and was bearing interest at a rate of 10% per annum payable at maturity. During the year ended January 31, 2015, the Company issued 19,922 shares of common stock of the Company in full and final settlement of this note, along with accrued interest of $4,685. This resulted in a loss on extinguishment of debt of $119,528 being recorded on the consolidated statements of operations during the year ended January 31, 2015. The fair value of the shares issued of $199,213 was determined with reference to the quoted market price of the Company’s common stock on the date of issuance. (iv) During the year ended January 31, 2015, the Company repaid two promissory notes in the aggregate principal amount of CDN$109,212. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $16,755) in respect of the accretion of the discounts on these notes and financing fees of $Nil (2015: $935) in respect of a finder’s fee paid in connection with the issuance of one of the notes. (v) On January 13, 2014, the Company issued a promissory note in the principal amount of $309,062, which was comprised of: (i) $250,000 consideration received; (ii) an OID of $37,500, being 15% of the proceeds received; and (iii) an amount of $21,562, being the remaining principal balance due under a separate note agreement with the same lender. The promissory note was repayable in five monthly instalments of $41,667 over the term of the note plus one final balloon payment of $63,229 at its maturity on July 13, 2014. The Company repaid this promissory note during the year ended January 31, 2015. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $33,972) in respect of the accretion of the discount on this note.

Convertible Promissory Notes Pa

Convertible Promissory Notes Payable	12 Months Ended
	Jan. 31, 2016
Convertible Promissory Notes Payable [Text Block]	9. Convertible Promissory Notes Payable January 31, 2016 January 31, 2015 Senior Secured Convertible Debentures, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to First and Second Kalamalka Amendment Agreement, due June 10, 2017 (i). $ - $ 7,169,832 First and Second Kalamalka Amendment Agreement, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to Senior Secured Convertible Debentures due October 1, 2016 (Note 9 (i)) (ii)) 600,000 600,000 Less: debt discounts - (7,163,982 ) 600,000 605,850 Less: current portion (600,000 ) - $ - $ 605,850 (i) Senior Secured Convertible Debentures On June 10, 2014 and July 8, 2014, the Company entered into Subscription Agreements (collectively, the “Subscription Agreements”) with several investors (collectively, the “Purchasers”) in connection with a private placement offering (the “Offering”) for aggregate gross proceeds of $7,309,832 through the sale of 292 units (the “Units”) at a price of $25,000 per Unit. Each Unit consisted of (i) a 6% convertible senior secured debenture in the principal amount of $25,000 (each, a “Debenture”) and (ii) warrants to purchase 4,167 of our common stock at an exercise price of $6.00 per share, subject to certain adjustment as set out in the warrant agreements (the “Warrants”). In connection with the close of the Offering, the Company issued Debentures in the aggregate principal amount of $7,309,832. As consideration, the Company (i) received gross cash proceeds equal to $6,094,100, before deducting agent fees and other transaction-related expenses; and (ii) exchanged 6% senior secured convertible notes in the aggregate amount of $1,094,159, being the principal and accrued interest due under such notes, for the issuance of Debentures in the aggregate principal amount of $1,215,732, at an exchange rate equal to 90% of the purchase price paid in the Offering. The aggregate principal amount was due on June 10, 2017 and was bearing interest at the rate of 6% per annum, payable semi-annually, in cash or in shares of common stock, at the option of the Company provided certain equity conditions of the Debentures had been met, valued at the then conversion price of the Debentures. During the year ended January 31, 2016, the Company issued an aggregate of 101,239 (2015: 48,750) shares of common stock as payment of $303,717 (2015: $146,245) in interest payable at regular interest payment dates under the terms of the Debentures. These shares of common stock were recorded at their fair value of $463,679 (2015: $274,823) on such interest payment dates, which was determined with reference to the quoted market price of the shares on such dates. The Debentures, along with any accrued and unpaid interest thereon, could be converted at any time, at the option of the holder, into common stock of the Company at a conversion price of $3.00 per share, subject to adjustment under the terms of the Debentures. Further, the Debentures would automatically convert into shares of the Company’s common stock (i) upon the closing of any financing with aggregate gross proceeds to the Company of at least $10,000,000 provided that the valuation of the Company was at least $50,000,000 or (ii) if the volume weighted average price of the Company’s shares was at or above $15 for at least 20 consecutive trading days. Repayment of the Debentures was collateralized against all the assets of the Company and its subsidiary, pursuant to a security agreement between the Company and an agent for the Purchasers. The Company issued an aggregate of 1,218,308 Warrants to the Purchasers to purchase, for a period of five years from the date of issuance, up to 1,218,308 shares of common stock at an initial exercise price of $6.00 per share, subject to adjustment. The Company has the right to call the Warrants if the volume weighted average closing price of its common stock exceeds $16.00 per share for more than 20 consecutive trading days at any time after June 10, 2016. In that event, the Warrants will expire 30 days following the date the Company delivers notice in writing to the Warrant holders announcing the call of the Warrants. At the date of issuance of the Debentures and Warrants, the Company was authorized to issue 2,500,000 shares of common stock, which was insufficient to settle the conversion of the Debentures and exercise of the Warrants. Consequently, under the guidance of ASC 815, management recorded a derivative financial instrument in the Company’s consolidated financial statements during the year ended January 31, 2015 (Note 11). In connection with the Subscription Agreements, the Company also entered into a Registration Rights Agreement with each Purchaser (the “Registration Rights Agreement”), pursuant to which the Company agreed to file with the Securities and Exchange Commission (the “SEC”) a registration statement to register for resale the shares that have been or may be issued to the Purchasers upon conversion of the Debentures and upon exercise of the Warrants (the “Registration Statement”). The terms of the Registration Rights Agreement also triggered the requirement to account for the related embedded conversion option and investor warrants that have not been included in an effective registration statement as derivative financial instruments pursuant to the guidance of ASC 815. The Company also agreed to grant piggyback registration rights whereby the Company is required to include the shares of common stock issuable pursuant to exercise of the Agent Warrants (as defined below) in the Registration Statement. The Company allocated the proceeds from the issuance of the Debentures first to the derivative financial instruments, at their fair values, with the remainder being allocated to the Debentures. The fair value of the derivative financial instruments of $19,338,215 at issuance resulted in a debt discount at issuance of $7,309,832, the entire aggregate principal balance of the Debentures. The remaining derivative financial instruments value over the proceeds of the debt at issuance of $12,028,383 was immediately expensed on the consolidated statements of operations as derivative expense, during the year ended January 31, 2015. This discount was being amortized using the effective interest method over the term of the Debentures. During the year ended January 31, 2016, the Company recorded regular accretion expense of $59,935 (2015: $5,895) in accretion of this discount. In connection with the Offering, the Company incurred finance fees of $2,021,213 as follows: (i) The Company paid a cash commission of $468,513, or 8% of the gross proceeds raised from certain of the Purchasers; (ii) The Company issued 276,592 warrants to acquire common stock equal to 8% of the aggregate number of shares issuable upon conversion of the Debentures and exercise of the Warrants with respect to certain of the Purchasers (the “Agent Warrants”), on the same terms as the Warrants, except that the Agent Warrants are (i) exercisable at 100% of the conversion or exercise price of the Debentures and Warrants issued to the Purchasers in the Offering and (ii) contain a cashless exercise provision. The fair value of the Agent Warrants of $1,552,700 was determined using an option pricing model under the following assumptions: June 10, 2014 July 8, 2014 Risk-free interest rate 1.71% 1.70% Expected life (years) 5.00 5.00 Expected volatility (1) 147.39% 147.39% Stock price at issuance $6.00 $6.50 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. The finance fees were allocated to the Debentures and related derivative financial instruments in the same proportion as the allocation of proceeds to each instrument at the issuance date and, consequently, since the derivative financial instruments were allocated 100% of the proceeds, these finance charges were allocated to the derivative financial instrument at issuance and, as a result of these instruments being carried at fair value, were recorded as an immediate finance expense on the consolidated statements of operations during the year ended January 31, 2015. On September 8, 2014, the Company filed registration statement on Form S-1 with the SEC to register the sale of up to 1,039,276 shares of common stock issuable upon exercise of certain of the warrants issued in connection with the Offering, including 60,000 warrants issued under the Kalamalka Notes (Note 9(ii)) which contained piggyback registration rights, and 979,276 of the Warrants. On October 8, 2014, the SEC declared the registration statement effective. During the year ended January 31, 2016, the Company issued an aggregate of 79,025 (2015: 46,667) shares of common stock pursuant to the conversion of debt, including 77,789 (2015: 46,667) shares for $233,358 (2015: $140,000) in principal amounts converted, and 1,236 (2015: nil) shares as payment of $3,706 (2015: $Nil) in accrued and unpaid interest, not inclusive of the Automatic Conversion described below. The Company also recorded accelerated accretion expense of $232,918 (2015: $139,896) in respect of principal amounts converted during the year, not inclusive of the Automatic Conversion described below. Effective August 3, 2015, the Company amended the Debentures via the written consent of the Company and the holders of a majority of the aggregate principal amount of the Debentures outstanding such that the automatic conversion provisions of the Debentures were amended to provide that (i) the Debentures would automatically convert into shares of the Company’s common stock upon the closing, or any combination of closings, of any equity offerings or financings with aggregate gross proceeds to the Company of at least $8,000,000 ; and (ii) the amount of principal and interest to be converted in connection with such an automatic conversion shall include an additional amount of interest equal to six (6) months of interest that would have accrued under the terms of the Debentures. On December 23, 2015, the Company completed an underwritten public offering of its common stock, which triggered the automatic conversion of the Debentures such that the outstanding aggregate principal amount of $6,936,450 plus outstanding accrued and unpaid interest of $37,805, and additional interest of $208,093, equal to six (6) months of interest that would have accrued under the terms of the Debentures (the “Bonus Interest”), was automatically converted into an aggregate of 2,394,116 shares of common stock at a conversion price equal to $3.00 per share (the “Automatic Conversion”). The Company accounted for the Automatic Conversion of the Debentures under the guidance of ASC 470- 20 Debt with Conversion and Other (ii) Senior Secured Convertible Note Agreements with Kalamalka Partners On August 10, 2012, and November 14, 2013, the Company and its wholly owned subsidiary, Naked, entered into certain Agency Agreements (the “Agency Agreements”) with Kalamalka and certain lenders (the “Lenders”) as set out in the Agency Agreements whereby the Company agreed to borrow up to $800,000 from the Lenders under a revolving loan arrangement by the issuance of convertible promissory notes (the “Notes”) from time to time as such funds are required by the Company. The Notes were collateralized by a first priority general security agreement over the present and future assets of the Company and were bearing interest at 12% per annum, calculated and payable monthly. The principal amounts outstanding under any Note and all accrued and unpaid interest therein, were convertible into common stock at $30 per share at any time at the option of the Lender. These terms were later amended, as described below. On November 14, 2013, the Company entered into another Agency and Interlender Agreement with Kalamalka and certain lenders whereby the Company agreed to borrow up to an additional $300,000. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $5,587) in respect of the accretion of the original debt discounts on these Notes, and $Nil (2015: $18,300) in financing charges in respect of the amortization of fees incurred in connection with their issuance and modification. On April 4, 2014, the Company entered into another Amendment Agreements with Kalamalka and certain of the Lenders (the “Amendment Agreements”). In connection with the Amendment Agreements, the Company amended several of the Notes in the aggregate principal amount of $600,000 as follows; (i) the Company extended the due date of the Notes to October 1, 2016; (ii) the Company reduced the interest rate accruing under the Notes to 6% per annum, calculated and payable quarterly; (iii) the Company removed certain borrowing margin requirements; (iv) the Company reduced the conversion price on Notes in the aggregate principal amount of $400,000 from $20 per share to $10 per share; and (v) 12,500 share purchase warrants exercisable at a strike price of $20 until August 10, 2017 held by Kalamalka and 2,500 share purchase warrants at a strike price of $20 until August 10, 2018 (the “Existing Warrants”) were exchanged for 15,000 New Warrants, as defined and described below (the “Exchanged Warrants”). As consideration for facilitating such amendments, the Company granted 45,000 share purchase warrants to the Lenders and Kalamalka (the “New Warrants”). Each New Warrant issued to Kalamalka and the Lenders is exercisable into one common share at a price of $6 per share for a period of five years. The Company has the right to call the New Warrants if the volume weighted average closing price of the Company’s shares exceeds $16 per share for more than 20 consecutive trading days at any time after June 10, 2016. In that event, the New Warrants will expire 30 days following the date the Company delivers notice in writing to the warrant holders announcing the call of the Warrants. In addition, the New Warrants contained piggyback registration rights on any subsequent registration statement filed with the SEC. The New Warrants were included in the registration statement declared effective by the SEC on October 8, 2014 (Note 9(i)). The Company assessed the guidance under ASC 470-60 Troubled Debt Restructurings Risk-free interest rate 0.66% Expected life (years) 2.50 Expected volatility (1) 141.72% Stock price $9.20 Dividend yields 0.00% The fair value of the New Warrants of $384,100 was determined using the Black Scholes option pricing model with the following assumptions: Risk-free interest rate 1.71% Expected life (years) 5.00 Expected volatility (1) 149.76% Stock price at date of issuance $9.20 Dividend yields 0.00% The fair value of the Exchanged Warrants of $23,300 was determined as the difference between the fair value of these warrants exchanged and the fair value of the New Warrants received. The fair values were determined using the Black Scholes option pricing model with the following weighted average assumptions: Existing Exchanged Warrants Warrants Risk-free interest rate 0.96% 1.71% Expected life (years) 3.52 5.00 Expected volatility (1) 146.70% 149.76% Stock price at date of issuance $9.20 $9.20 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. The loss was recorded on the consolidated statement of operations during the year ended January 31, 2015, with a corresponding credit to additional paid in capital. In connection with the Amendment Agreements, the Company incurred $36,993 in financing fees. These costs have been recorded as a deferred financing charge and are being amortized using the effective interest method over the term of the amended Notes. During the year ended January 31, 2016, the Company recorded financing expense of $28,364 (2015: $23,043) in respect of the amortization of these charges. During the year ended January 31, 2015, the remaining Note in the aggregate principal amount of $100,000 plus $1,868 in accrued interest therein was settled by the issuance of 25,467 common stock of the Company at a conversion price of $4 per share. The Company recorded debt conversion expense of $187,438, related to the fair value of the additional units issued as a result of converting at the lower conversion price than the contractual conversion rate. The fair value of the shares issued of $289,306 was determined with reference to their quoted market price on the date of issuance. (iii) On June 5, 2014, the Company entered into a Note Termination Agreement pursuant to which the Company agreed to settle the full amount outstanding under a convertible promissory note in the principal amount of $124,444 in exchange for (i) a one-time cash payment of $175,000 and (ii) 8,250 common stock of the Company. The promissory note had been convertible, at any time by the lender, into shares of common stock of the Company at a price which is the lesser of $10.60 or 60% of the lowest trade price in the 25 trading days prior to the conversion (the “Conversion Price”). This resulted in a loss on extinguishment of debt of $38,405, being the fair value of aggregate consideration given of $217,240 less the book value of this Note of $3,735 (after a debt discount of $120,709) and a related embedded conversion feature being accounted for as a derivative liability of $175,100. The fair value of the shares issued of $42,240 was determined with reference to the quoted market price of the Company’s common stock on the date of issuance. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $2,065) in respect of the accretion of the discount on this note. (iv) During the year ended January 31, 2015, the Company repaid various convertible promissory notes in the aggregate principal amount of $133,500 through cash payments of $189,640. The repayment of these promissory notes resulted in net gains on extinguishment of debt of $32,958, being the cash consideration paid upon redemption less the carrying value of the Note and any related embedded conversion features of $64,900, which were being accounted for as derivative financial instruments. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $20,106) in respect of the accretion of the discount on this note and financing charges of $Nil (2015: $17,124) in respect of the amortization of third party debt issuance costs incurred in connection with this note. (v) During the year ended January 31, 2015, the Company repaid a convertible promissory note in the principal amount of $128,705 through a debt settlement agreement with the lender whereby the Company agreed to exchange the remaining outstanding principal amount for a 6% senior secured convertible note, which was later converted into a Subsequent Financing. (Note 9(i)). The Company assessed the guidance under ASC 470-60 Troubled Debt Restructurings and determined that this guidance did not apply to the exchange of debt instruments. Under the guidance of ASC 470-50, the exchange was considered a substantial change in the terms of the loan facility and, accordingly, the Company applied debt extinguishment accounting. The Company calculated the fair value of the amended Note by discounting future cash flows using a discount rate representative of current borrowing rates for debt instruments and valuing the discount included in the amended note with respect to its conversion into a Subsequent Financing (Note 9(i)). There was a trivial gain on settlement which was not recorded in these consolidated financial statements. During the year ended January 31, 2016, the Company recorded accretion expense of $Nil (2015: $7,754) in respect of the accretion of the discount on this note and financing charges of $Nil (2015: $4,857) in respect of the amortization of third party debt issuance costs and interest costs incurred in connection with this note.

Derivative financial instrument

Derivative financial instruments	12 Months Ended
	Jan. 31, 2016
Derivative financial instruments [Text Block]	10. Derivative financial instruments The following table presents the components of the Company’s derivative financial instruments associated with convertible promissory notes (Notes 9 (i)), which have no observable market data and are derived using an option pricing model measured at fair value on a recurring basis, using Level 3 inputs to the fair value hierarchy, at January 31, 2016 and 2015: 2016 2015 Embedded conversion features $ - $ 1,769,100 Warrants - 2,030,850 $ - $ 3,799,950 These derivative financial instruments arise as a result of applying ASC 815, which requires the Company to make a determination whether an equity-linked financial instrument, or embedded feature, is indexed to the entity’s own stock. This guidance applies to any freestanding financial instrument or embedded features that have the characteristics of a derivative, and to any freestanding financial instruments that are potentially settled in an entity’s own stock. During the year ended January 31, 2015, the Company issued notes with embedded conversion features and warrants to purchase common stock and the Company did not, at the date of issuance of these instruments, have a sufficient number of authorized and available shares of common stock to settle the outstanding contracts (Note 9(i)). Further, these embedded conversion features and warrants issued during the year ended January 31, 2015 were subject to a registration rights agreement which, pursuant to the terms of this agreement, triggered the requirement to account for these instruments as derivative financial instruments until such time as the shares become eligible for sale without volume limitations or other restrictions. As a result, the Company was required to account for these instruments as derivative financial instruments until such time as the shares were no longer subject to the constraints of the registration rights agreement. During the year ended January 31, 2015, the Company received stockholder approval through written stockholder consent to increase the authorized shares of common stock in the Company from 2,500,000 to 11,250,000, which amount was sufficient to fully settle all the outstanding contracts. In addition, during the year ended January 31, 2015, the registration statement covering the resale of certain of the warrants covered under the Registration Rights Agreement that were required to be accounted for as derivative liabilities, was filed with and was declared effective by the SEC. Additionally, certain registration exemptions were triggered to permit the resale of certain of the shares underlying embedded conversion features. During the year ended January 31, 2016, the Company obtained a waiver of the Registration Rights Agreement from certain remaining debenture holders, waiving their rights under the registration rights agreement that were triggering liability accounting. Consequently, these warrants and embedded conversion features are no longer required to be accounted for as liabilities. Pursuant to the guidance of ASC 815, the Company reclassified the fair value of these instruments on the date of the triggering event or modification into equity, with the change in fair value up to the date of modification being recorded on the consolidated statements of operations as other income. As a result of the application of ASC 815, the Company has recorded these derivative financial instruments for the year ended January 31, 2016 and 2015 at their fair value as follows: 2016 2015 Derivative financial instruments, beginning of the year $ 3,799,950 $ 241,618 Fair value of warrants and embedded conversion features at commitment dates - 20,890,900 Fair value mark to market adjustments (708,900 ) (1,921,568 ) Extinguishment of derivative liability upon extinguishment of host contract - (240,000 ) Reclassification of derivative liability upon change in triggering events (3,091,050 ) (15,171,000 ) Derivative financial instruments, end of the year $ - $ 3,799,950 During the year ended January 31, 2016, the Company recorded other income of $708,900 (2015: $1,921,568) related to the change in fair value of the warrants and embedded conversion features, which is presented in the change in fair value of derivative financial instruments in the accompanying consolidated statements of operations. The embedded conversion features and warrants accounted for as derivative financial instruments have no observable market and the Company estimated their fair values at January 31, 2015 using the binomial option pricing model based on the following weighted average management assumptions: Reclassification January 31, Date 2015 Risk-free interest rate 0.89% 0.92% Expected life (years) 3.17 3.42 Expected volatility (1) 115.02% 136.25% Stock price $4.40 $4.80 Dividend yields 0.00% 0.00% (1) During the year ended January 31, 2015, the Company repaid certain promissory notes which contained derivative financial instruments and the corresponding derivative financial instrument were extinguished upon extinguishment of the related host contract.

Stockholders Equity

Stockholders Equity	12 Months Ended
	Jan. 31, 2016
Stockholders Equity [Text Block]	11. Stockholders’ Equity Effective August 10, 2015, the Company effected a reverse stock split of the basis of 1:40. As such, the Company’s authorized capital was decreased from 450,000,000 shares of common stock to 11,250,000 shares of common stock and an aggregate of 53,278,818 shares of common stock issued and outstanding were decreased to 1,331,977 shares of common stock. These financial statements give retroactive effect to such reverse stock split and all share and per share amounts have been adjusted accordingly. Authorized 11,250,000 shares of common stock, par value $0.001. Year ended January 31, 2016 i) In connection with a debt settlement agreement, the Company issued 2,500 shares of common stock to a consultant of the Company in exchange for services rendered. The fair value of $4.80 per share was determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. There was no gain or loss recorded in connection with issuance of these shares. ii) On July 3, 2015, the Company issued an aggregate 205,248 shares of common stock at $4 per share, in connection with warrant amendment agreements (the “Warrant Amendments”) for gross proceeds of $821,000. Under the terms of the Warrant Amendments, the holders of such warrants elected to reduce the exercise price of the warrants from $6 to $4, subject to a shortened exercise period and subject to certain resale restrictions on the shares issuable upon exercise of such warrants. Of the total, an aggregate of 140,249 of the shares issued were issued to the CEO and a director of the Company, for an aggregate exercise price of $560,996. The Company determined that the Warrant Amendments must be accounted for using modification accounting pursuant to the guidance under Accounting Standards Codification 718 (“ASC 718”). Under this guidance, a short-term inducement offer shall be accounted for as a modification of the terms of equity based awards, to the extent that the inducement is accepted by the equity holders. Modification accounting requires the incremental fair value of the instrument arising from the modification to be recognized as an expense on the income statement, or a charge directly to equity, depending on the nature of the offer. The Company determined that it was appropriate to record the incremental fair value of the Warrant Amendments as an expense on the income statement and consequently the Company recorded the incremental fair value as a component of general and administrative expenses on the consolidated statement of operations for the year ended January 31, 2016. The Company determined that the incremental fair value of the instruments arising from the modification was $32,800, based on the difference between the fair value of the warrants immediately prior to the amendment and the fair value of these instruments immediately after the amendment. The fair values were determined using the Black Scholes option pricing model based on the following assumptions: risk free interest rate 1.33%, expected life: 3.94 years, expected volatility: 139.54%, dividend yields: 0.00%. iii) On August 3, 2015, the Company consummated a tender offer to amend and exercise certain warrants to purchase common stock of the Company. Under the terms of the tender offer, the holders of such warrants elected to reduce the exercise price of the warrants from $6 to $4, subject to a shortened exercise period and subject to certain resale restrictions on the shares issuable upon exercise of such warrants. Pursuant to the tender offer, the holders of an aggregate of 380,461 warrants agreed to amend their warrants and tendered and exercised such warrants for gross proceeds to the Company of $1,521,829. In connection with the tender offer, the Company incurred issuance costs of $91,422. The Company determined that the Warrant Amendments must be accounted for using modification accounting pursuant to the guidance under Accounting Standards Codification 718 (“ASC 718”). Under this guidance, a short-term inducement offer shall be accounted for as a modification of the terms of equity based awards, to the extent that the inducement is accepted by the equity holders. Modification accounting requires the incremental fair value of the instrument arising from the modification to be recognized as an expense on the income statement, or a charge directly to equity, depending on the nature of the offer. The Company determined that it was appropriate to record the incremental fair value of the Warrant Amendments as an expense on the income statement and consequently the Company recorded the incremental fair value as a finance fee on the consolidated statement of operations for the year ended January 31, 2016. The Company determined that the incremental fair value of the instruments arising from the modification was $63,000, based on the difference between the fair value of the warrants immediately prior to the amendment and the fair value of these instruments immediately after the amendment. The fair values were determined using the Black Scholes option pricing model based on the following assumptions: risk free interest rate 1.26%, expected life: 3.86 years, expected volatility: 138.81%, dividend yields: 0.00%. iv) On December 23, 2015, the Company completed an underwritten public offering of 1,875,000 shares of its common stock at $4 per share for gross proceeds of $7,500,000. In connection with the offering, the Company incurred share issuance costs of $623,720 consisting of (i) a cash commissions equal to 8% of the gross proceeds from certain participants, equal to $548,720 ; (ii) warrants to purchase that number of shares of common stock equal to 8% of the shares sold in the offering, equal to 137,180 share purchase warrants and (iii) underwriter legal fees equal to $75,000. Year ended January 31, 2015 v) On May 12, 2014, the Company issued an aggregate of 45,388 shares of common stock in settlement of loans outstanding of $180,703, including aggregate accrued interest of $5,703. vi) On June 17, 2014, the Company issued 8,250 common stock as partial consideration related to the settlement of a loan outstanding of $124,444. vii) On June 17, 2014, the Company issued 1,505 common stock as payment to a vendor for fees rendered, pursuant to a debt settlement agreement dated May 16, 2014 whereby the Company agreed to settle $4,605 (CDN$5,000) in amounts owing to the vendor. This resulted in a loss on extinguishment of debt of $3,945. The fair value of the shares issued of $8,550 was determined with reference to the quoted market price of the Company’s stock on the date of issuance. viii) On September 25, 2014, the Company issued 5,625 common stock to a director of the Company as consideration under a board agreement dated September 24, 2013 (the “Board Agreement”). These shares were recorded at their fair values on the date they were committed to be issued pursuant to the Board Agreement. The fair values per share were determined with reference to the quoted market price of the Company’s stock on the respective commitment dates. 2014 Stock Option Plan On June 6, 2014, the Company’s board of directors approved a 2014 Long-Term Incentive Plan (the “2014 Plan”), which provides for the grant of stock options, restricted shares, restricted share units and performance stock and units to directors, officers, employees and consultants of the Company. Stockholder approval of the plan was obtained on August 21, 2014. The maximum number of our common stock reserved for issue under the plan is 2,750,000 shares subject to adjustment in the event of a change of the Company’s capitalization (as described in the 2014 Plan). As a result of the adoption of the 2014 Plan, no further option awards will be granted under any previously existing stock option plan. Stock option awards previously granted under previously existing stock option plans remain outstanding in accordance with their terms. The 2014 Plan is administered by the board of directors, except that it may, in its discretion, delegate such responsibility to a committee of such board. The exercise price will be determined by the board of directors at the time of grant. Stock options may be granted under the 2014 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may be determined by the board, subject to earlier termination in accordance with the terms of the 2014 Plan. At January 31, 2016, 607,101 (2015: 1,025,750) options remain available for issuance under the 2014 Plan. Stock Based Compensation A summary of the status of the Company’s outstanding stock options for the period ended January 31, 2016 is presented below: Weighted Weighted Average Number Average Grant Date of Options Exercise Price Fair Value Outstanding at February 1, 2014 75,125 $ 13.60 Expired (7,125 ) $ 10.00 Granted 1,726,875 $ 5.20 $ 8.40 Outstanding at January 31, 2015 1,794,875 $ 5.48 $ 8.40 Expired (22,250 ) $ 22.81 Forfeited (3,750 ) $ 4.48 Granted 422,399 $ 4.48 $ 4.15 Outstanding at January 31, 2016 2,191,274 $ 5.12 Exercisable at January 31, 2016 1,238,402 $ 5.26 At January 31, 2016, the following stock options were outstanding, entitling the holder thereof to purchase common stock of the Company as follows: Exercise Expiry Number Number Price Date Vested 1,375 $10.00 April 1, 2016 1,375 15,000 $10.00 October 9, 2017 15,000 1,250 $10.00 February 1, 2018 1,250 3,750 $10.00 May 1, 2018 3,750 2,000 $10.00 April 1, 2019 2,000 25,000 $10.00 July 30, 2022 25,000 1,699,250 $5.12 June 6, 2024 1,068,813 25,000 $6.00 June 10, 2024 15,000 37,500 $4.48 February 3, 2025 - 37,500 $4.48 February 25, 2025 - 6,250 $4.80 July 6, 2025 - 337,399 $4.40 August 18, 2025 106,214 2,191,274 1,238,402 The aggregate intrinsic value of stock options outstanding is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s common stock. At January 31, 2016, the aggregate intrinsic value of stock options outstanding is $Nil and exercisable is $Nil (2015: $Nil and $Nil, respectively). During the year ended January 31, 2016, the Company recognized a total fair value of $5,374,465 (2015: $3,318,241) of stock based compensation expense relating to the issuance of stock options in exchange for services. An amount of approximately $7,881,830 in stock based compensation expense is expected to be recognized over the remaining vesting term of these options to August, 2018. The fair value of each option award was estimated on the date of the grant using the Black-Scholes option pricing model based on the following weighted average assumptions: 2016 2015 Expected term of stock option (years) (1) 6.43 6.54 Expected volatility (2) 124.33% 110.84% Stock price at date of issuance $ 4.71 $ 5.20 Risk-free interest rate 1.81% 2.07% Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate the expected term of the options, the Company has elected to apply the short-cut method to determine the expected term under the guidance of Staff Accounting Bulletin No. 110 (“SAB 110 ”). (2) Share Purchase Warrants At January 31, 2016, the Company had 1,645,198 share purchase warrants outstanding as follows: Exercise Expiry Number Price Date 6,250 $4.00 November 14, 2016 6,250 $4.00 November 26, 2016 5,688 $4.00 December 24, 2016 12,451 $10.00 August 10, 2017 3,750 $10.00 August 10, 2018 60,001 $6.00 April 4, 2019 555,968 $6.00 June 10, 2019 155,052 $3.00 June 10, 2019 168,883 $6.00 July 8, 2019 29,343 $3.00 July 8, 2019 24,625 $8.00 October 23, 2019 137,180 $4.80 December 23, 2020 365,688 $4.80 June 15, 2022 36,569 (1) $4.80 June 15, 2022 15,000 $4.80 July 6, 2022 62,500 $5.11 September 1, 2022 1,645,198 (1) These warrants may vest and become exercisable only under certain anti-dilution performance conditions contained in the warrant During the year ended January 31, 2016, the Company issued an aggregate of 479,756 warrants exercisable at a weighted average exercise price of $4.84 per share for a period of seven years from the date of issuance, pursuant to negotiated consulting and endorsement agreements. The weighted average grant date fair value of these warrants at issuance was $4.67 for an aggregate grant date fair value of $2,239,000, based on the Black-Scholes option pricing model using the following weighted average assumptions: expected term 7 years, expected volatility 158.04%, expected dividend yield 0.00%, risk free interest rate 2.09% . Stock based compensation is being recorded in the financial statements over the vesting term of three years from the date of grant. The Company recognized stock based compensation expense of $257,802 during the year ended January 31, 2016 (2015: $Nil) in connection with warrants granted. Certain of the warrants granted during the year ended January 31, 2016 become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement. The fair value of these warrants at issuance was calculated to be $168,500 based on the Black-Scholes option pricing model using the following assumptions: expected term 7 years, expected volatility 153.00%, expected dividend yield 0.00%, risk free interest rate 2.11% . No stock-based compensation has been recorded in the financial statements as none of the performance conditions have yet been met. A summary of the Company’s share purchase warrants outstanding is presented below: Weighted Number of Average Warrants Exercise Price Outstanding at February 1, 2014 94,262 $ 16.00 Cancelled (15,000 ) $ 20.00 Issued 1,579,581 $ 5.60 Expired (30,262 ) $ 25.60 Outstanding at January 31, 2015 1,628,581 $ 5.74 Issued 616,937 $ 4.83 Exercised (585,709 ) $ 6.00 Expired (14,611 ) $ 9.82 Outstanding at January 31, 2016 1,645,198 $ 5.27

Income Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2016
Income Taxes [Text Block]	12. Income Taxes The reconciliation of income tax provision computed at statutory rates to reported income tax provision is as follows: January 31, 2016 2015 34% 34% Loss for the year $ (19,063,399 ) $ (21,078,265 ) Expected income tax recovery (6,482,000 ) (7,167,000 ) Non-deductible other expenses 21,000 483,000 Non-deductible accretion and financing fees 2,467,000 541,500 Non-deductible derivative expense - 4,090,000 Non-deductible derivative mark-to-market adjustments (241,000 ) (653,000 ) Effect of foreign exchange and other adjustments (4,000 ) (1,000 ) True up to prior years’ tax provision (120,600 ) - Change in valuation allowance 4,359,600 2,706,000 Total income tax expense $ - $ - Significant components of the Company’s net deferred tax assets at January 31, 2016 and 2015: January 31, 2016 2015 Temporary differences relating to: Net operating loss carry forwards $ 5,968,100 $ 3,627,000 Equipment and intangible assets 25,700 12,800 Stock based compensation 3,457,200 1,451,600 9,451,000 5,091,400 Valuation allowance (9,451,000 ) (5,091,400 ) Net deferred taxes $ - $ - Deferred tax assets and liabilities are determined based on temporary basis differences between assets and liabilities reported for financial reporting and tax reporting. The ultimate realization of the net deferred tax asset is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company considers projected future taxable income, recent financial performance and tax planning strategies in making this assessment. The Company is required to record a valuation allowance to reduce its net deferred tax asset to the amount that is more likely than not to be realized. Accounting guidance allows the Company to look to future earnings to support the realizability of the net deferred assets. Since the Company has had cumulative net operating losses since inception, the ability to use forecasted future earnings is diminished. As a result, the Company concluded a full valuation allowance against the net deferred tax asset was appropriate. At January 31, 2016 and 2015 the total change in valuation allowance for items affecting the current year was $4,359,600 and $2,706,000, respectively. At January 31, 2016, the Company had accumulated net operating losses in Canada totaling approximately $5,066,000 (2015: $1,800,000), which may be available to reduce taxable income in Canada in future taxation years. At January 31, 2016, the Company had accumulated net operating losses in the United States totaling approximately $17,483,000 (2015: $10,666,000), which may be available to reduce taxable income in the United States in future taxation years. Unless previously utilized, these net operating losses will begin to expire in 2025. The Company files income tax returns in the United States and Canada. All of the Company’s tax returns are subject to tax examinations until the respective statute of limitations expires. The Company currently has no tax years under examination. The Company’s tax filings for the fiscal years 2012 to 2016 remain open to examination. Based on management’s assessment of ASC Topic 740 Income Taxes Under Internal Revenue Code (“IRC”) Sections 382, annual use of the Company’s net operating loss carryforwards to offset taxable income may be limited based on cumulative changes in ownership. The Company has not completed an analysis to determine whether any such limitations have been triggered as of January 31, 2016. The Company has no income tax effect due to the recognition of a full valuation allowance on the expected tax benefits of future loss carry forwards based on uncertainty surrounding realization of such assets.

Customer Concentrations

Customer Concentrations	12 Months Ended
	Jan. 31, 2016
Customer Concentrations [Text Block]	13. Customer Concentrations The Company has concentrations in the volumes of business transacted with particular customers. The loss of these customers could have a material adverse effect on the Company’s business. For the year ended January 31, 2016, the Company had concentrations of sales with a customer equal to 41% of the Company’s net sales (2015: 28%). As at January 31, 2016, the accounts receivable balance for this customer was $73,347 (2015: $2,755).

Commitments

Commitments	12 Months Ended
	Jan. 31, 2016
Commitments [Text Block]	14. Commitments i) In accordance with a negotiated agreement, the Company paid a non-refundable guaranteed advance on royalties of $50,000 during the year ended January 31, 2016, and is required to pay royalty fees based on the greater of a pre-determined percentage not to exceed 10% of net wholesale sales, as defined in such agreements, or a minimum annual amount. Minimum royalty payments are being amortized to operations over the period for which royalties accrue under the terms of the agreement. During the year ended January 31, 2016, $75,000 (2015: $Nil) in royalties were amortized to operations. The Company is committed to future minimum royalty payments as follows: Year ending January 31, Amount 2017 $ 312,500 2018 350,000 2019 350,000 2020 262,500 $ 1,275,000 ii) Pursuant to a Strategic Consulting and Collaboration Agreement, the Company is committed to pay a monthly cash retainer ranging from $10,000 to $20,000 over the three-year term of the Agreement. Subsequent to January 31, 2016, the Company negotiated a 6 month hold on the monthly cash retainer, effective March 1, 2016. Future commitments over the remaining term of the agreement are as follows: Year ending January 31, Amount 2017 $ 60,000 2018 175,000 2019 235,000 2020 20,000 $ 490,000

Summary of Significant Accoun21

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2016
Principles of Consolidation and Basis of Accounting [Policy Text Block]	Principles of Consolidation and Basis of Accounting These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary, Naked. All inter-company transactions and balances have been eliminated.
Reporting Currency and Foreign Currency [Policy Text Block]	Reporting Currency and Foreign Currency The functional currency of the Company is the US dollar. Transaction amounts denominated in foreign currencies are translated into their US dollar equivalents at exchange rates prevailing at the transaction dates. Financial instruments denominated in foreign currencies are revalued each period at exchange rates prevailing at each balance sheet date until settled. Foreign currency gains and losses on transactions or settlements are recognized in the consolidated statement of operations. These consolidated financial statements have been presented in US dollars, which is the Company’s reporting currency.
Basis of Presentation [Policy Text Block]	Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with GAAP in the United States of America.
Segment Reporting [Policy Text Block]	Segment Reporting The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. The Company’s chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. Accordingly, the Company has determined that as of January 31, 2016 and 2015, there is only a single reportable operating segment. The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. Revenues from external customers are all derived from customers located within North America as follows: 2016 2015 United States $ 1,090,024 $ 343,769 Canada 299,390 213,443 $ 1,389,414 $ 557,212 At January 31, 2016, the net book value of long-lived assets all located within North America were as follows: 2016 2015 Equipment Intangible assets Equipment Intangible assets United States $ 7,091 $ 53,738 $ 12,688 $ 14,211 Canada 6,124 19,357 8,453 29,945 $ 13,215 $ 73,095 $ 21,141 $ 44,156
Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts [Policy Text Block]	Revenue Recognition, Accounts Receivable and Allowance for Doubtful Accounts Sales are recorded when title and risk of loss has passed to the customer, when persuasive evidence of a sales arrangement exists, the selling price is fixed and determinable and collectability is reasonable assured. Accounts receivable consist of amounts due from customers and are recorded upon the sale of product to customers. Credit terms are extended to customers in the normal course of business and no collateral is required. The Company estimates an allowance for doubtful accounts based on historical losses, the existing economic conditions and the financial stability of its customers. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received.
Inventory [Policy Text Block]	Inventory Inventory is stated at the lower of cost or market value. Cost is determined using the weighted average method, which under the circumstances, management believes will provide for the most practical basis for the measurement of periodic income. Management periodically reviews inventory for slow moving or obsolete items and considers realizability based on the Company’s marketing strategies and sales forecasts to determine if an allowance is necessary. If market value is below cost then an allowance is created to adjust the carrying amount of inventory.
Equipment [Policy Text Block]	Equipment Equipment is recorded at cost. Equipment is depreciated using the straight-line method over the estimated useful lives. The estimated useful lives for each asset group are as follows: Years Furniture and equipment 5 Computer equipment 2 At the time depreciable property is retired or otherwise disposed of the related cost and accumulated depreciation is removed from the accounts and any resulting gain or loss is reflected in the consolidated statement of operations.
Intangible Assets [Policy Text Block]	Intangible Assets Indefinite-life intangible assets, consisting of costs to acquire trademarks with an indefinite life, are recorded at cost, net of impairment charges, if applicable. No amortization has been taken on indefinite life intangible assets. Indefinite-life intangible assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
Website Costs [Policy Text Block]	Website Costs The Company recognizes the costs associated with developing a website in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 350–40, Website development costs Internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred to develop internal–use computer software during the application development stage are capitalized. Training costs are not internal–use software development costs and, if incurred during this stage, are expensed as incurred. These capitalized costs are amortized based on their estimated useful life over two years.
Impairment of Long-Lived Assets [Policy Text Block]	Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the related carry amounts may not be recoverable. Such a review involves assessing qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that a long-lived asset is impaired. If the Company assesses that there is a likelihood of impairment, then the Company will perform a quantitative analysis comparing the carrying value of the assets with the estimated future net undiscounted cash flows expected to result from the use of the assets, including cash flows from disposition. Should the sum of the expected future net cash flows be less than the carrying value, the Company would recognize an impairment loss at that date for the amount by which the carrying amount of the asset exceeds its fair value. Management has determined that no impairment has been identified in the years ended January 31, 2016 or 2015.
Shipping and Handling Costs [Policy Text Block]	Shipping and Handling Costs Costs associated with the Company’s third-party shipping, warehousing and handling activities are included within operating expenses on the consolidated statements of operations. (i) Shipping costs associated with marketing related promotions are included as a component of general and administrative expenses. These shipping costs were $10,440 for the year ended January 31, 2016 ($25,930 for the year ended January 31, 2015). (ii) Shipping costs billed to customers are recorded as revenues and related out-bound shipping costs incurred by the Company are recorded as cost of sales. (iii) Warehousing and handling costs, and shipping costs associated with transfers of inventory to and from third party warehouses to the Company’s warehouse are included in general and administrative expense as warehouse management. These warehousing, shipping and handling costs were $404,092 for the year ended January 31, 2016 ($91,000 for the year ended January 31, 2015).
Advertising Expense [Policy Text Block]	Advertising Expense The Company expenses advertising costs to operations during the period in which they are incurred. The Company expensed $201,198 and $38,278 related to advertising for the years ended January 31, 2016 and 2015, respectively.
Income Taxes [Policy Text Block]	Income Taxes The current income tax represents the amount of income taxes expected to be paid or the benefit expected to be received for the current year taxable income or loss. Deferred income taxes are recognized for the future tax consequences of temporary differences arising between the carrying value of assets and liabilities for financial statement and tax reporting purposes. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. In assessing the recoverability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which those temporary differences become deductible. Management considers projected future taxable income and tax planning strategies in making this assessment. The Company recognizes the impact of a tax position in the consolidated financial statements if the position is more likely than not to be sustained upon examination on the technical merits of the position. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits and penalties as income tax expense. The Company has no uncertain tax positions as of January 31, 2016 and 2015, respectively; consequently, no interest or penalties have been accrued by the Company.
Fair Value of Financial Instruments [Policy Text Block]	Fair Value of Financial Instruments The Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, Fair Value Measurements and Disclosures Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; and Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The Company’s financial instruments consist of cash, accounts receivable, accounts payable, notes payable, related party payables and convertible promissory notes. Other than convertible promissory notes, the fair values of these financial instruments approximate their respective carrying values because of the short maturity of these instruments. The Company determined that the aggregate fair value of promissory notes payable outstanding at January 31, 2016 and 2015, based on Level 2 inputs in the fair value hierarchy, was equal to their aggregate book value based on the short maturities and current borrowing rates available to the Company. The fair value of the Company’s convertible promissory notes is based on Level 3 inputs in the fair value hierarchy. The Company calculated the fair value of these notes by discounting future cash flows using rates representative of current borrowing rates for debt instruments without a conversion feature and by using the Black Scholes option pricing model to determine the fair value of the conversion feature using the following assumptions: 2016 2015 Risk-free interest rate 0.33% 0.61% Expected life (years) 0.67 2.34 Expected volatility (1) 91.47% 147.42% Stock price $2.79 $4.80 Dividend yields 0.00% 0.00% (1) The Company determined that the fair value of the convertible promissory notes at January 31, 2016 was $567,776 (2015: $15,476,300) based on a market interest rate of 18%.
Debt issuance costs [Policy Text Block]	Debt issuance costs The Company incurs costs in connection with debt issuances, such as commissions and professional fees. Debt issuance costs are initially recorded as deferred financing expense on the consolidated balance sheets, and are amortized to financing expense over the term of the respective borrowings using the effective interest method. Any costs incurred or paid to the lender in connection with the issuance of debt represent a reduction in the proceeds received by the Company. The resulting discount is amortized as accretion expense over the term of the debt using the effective interest method.
Derivative Financial Instruments [Policy Text Block]	Derivative Financial Instruments The Company evaluates stock options, stock warrants and other contracts to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for under the relevant sections of ASC 815-40, Derivative Instruments and Hedging: Contracts in Entity’s Own Equity (“ASC 815”). Certain of the Company’s embedded conversion features on debt and outstanding warrants are treated as derivative liabilities for accounting purposes under ASC 815 due to insufficient authorized shares to settle these outstanding contracts, or due to other rights connected with these contracts, such as registration rights. In the case of insufficient authorized share capital available to fully settle outstanding contracts, the Company utilizes the latest inception date sequencing method to reclassify outstanding contracts as derivative instruments. These contracts are recognized currently in earnings until such time as the warrants are exercised, expire, the related rights have been waived and/or the authorized share capital has been amended to accommodate settlement of these contracts. These instruments do not trade in an active securities market. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Derivative instruments that become subject to reclassification are reclassified at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as current or non-current based on whether or not settlement of the derivative instrument is expected within 12 months of the balance sheet date. The Company estimates the fair value of these instruments using the binomial option pricing model. This model uses Level 3 inputs in the fair value hierarchy established by ASC 820 .
Use of Estimates [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. The most significant estimates made by the Company are those relating to uncollectible receivables, inventory valuation and obsolescence, product returns, and derivative valuations.
Loss per share [Policy Text Block]	Loss per share Earnings or loss per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted EPS is computed by dividing net income (loss) by the weighted-average of all potentially dilutive shares of common stock that were outstanding during the periods presented. The treasury stock method is used in calculating diluted EPS for potentially dilutive stock options and share purchase warrants, which assumes that any proceeds received from the exercise of in-the-money stock options and share purchase warrants, would be used to purchase common stock at the average market price for the period. EPS for convertible debt is calculated under the “if-converted” method. Under the if converted method, EPS is calculated as the more dilutive of EPS (i) including all interest (both cash interest and non-cash discount amortization) and excluding all shares underlying the convertible debt or; (ii) excluding all interest and costs directly related to the convertible debt (both cash interest and non-cash discount amortization) and including all shares underlying the convertible debt. For the years ended January 31, 2016 and 2015, diluted EPS was calculated by including interest expense related to the convertible debt and excluding the shares underlying the convertible debt. Net loss per share was determined as follows: 2016 2015 Numerator Net loss $ (19,063,399 ) $ (21,078,265 ) Denominator Weighted average shares outstanding 1,881,901 903,659 Effect of dilutive securities Warrants and options - - Convertible debt - - Diluted weighted average shares outstanding 1,881,901 903,659 Basic net loss per share $ (10.13 ) $ (23.33 ) Diluted net loss per share $ (10.13 ) $ (23.33 ) Anti-dilutive securities not included in diluted loss per share relating to: Warrants and options outstanding 3,836,472 3,423,399 Convertible debt 60,000 2,449,944 3,896,472 5,873,343
Accounting for Stock-Based Compensation [Policy Text Block]	Accounting for Stock-Based Compensation ASC Topic 718, Compensation – Stock Compensation The Company accounts for the granting of equity based awards to employees using the fair value method whereby all awards to employees will be recorded at fair value on the date of the grant. The fair value of all equity based awards is expensed over their vesting period with a corresponding increase to additional paid in capital. Compensation costs for stock-based payments to employees with graded vesting are recognized on a straight-line basis. The amount of cumulated compensation expense recognized at any date must at least equal the portion of the grant date value of the award that is vested at that date. Based on guidance in ASC 505-50, stock-based payments to non-employees are measured at the fair value of the consideration received, or the fair value of the equity instruments issued, or liabilities incurred, whichever is more reliably measurable. The fair value of stock-based payments to non-employees is periodically remeasured until the counterparty performance is complete, and any change therein is recognized over the vesting period of the award. Compensation costs for stock-based payments with graded vesting are recognized on a straight-line basis. The cost of the stock-based payments to non-employees that are fully vested and non-forfeitable as at the grant date are measured and recognized at that date, unless there is a contractual term for services in which case such compensation would be amortized over the contractual term.
New Accounting Pronouncements [Policy Text Block]	New Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB, which are adopted by the Company as of the specified date. Unless otherwise discussed, management believes the impact of recently issued standards, which are not yet effective, will not have a material impact on our consolidated financial statements upon adoption. In May 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2014-09, "Revenue from Contracts with Customers". The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The premise of the guidance is that a Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 can be adopted by the Company either retrospectively or as a cumulative-effect adjustment as of the date of adoption. On April 1, 2015, the FASB decided to defer the effective date of the new revenue standard by one year. As a result, public entities would apply the new revenue standard to annual reporting periods beginning after December 15, 2017. The Company has not yet evaluated the impact of the adoption of this new standard. In June 2014, the FASB issued ASU No. 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 will explicitly require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In April 2015, the FASB, issued the Accounting Standards Update 2015-03, Interest - Imputation of Interest (Subtopic 835-30) - Simplifying the Presentation of Debt Issuance Costs, that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. For public business entities, the final guidance will be effective for fiscal years beginning after December 15, 2015, however, early adoption (including in interim periods) is permitted. Upon adoption, an entity must apply the new guidance retrospectively to all prior periods presented in the financial statements. An entity is also required in the year of adoption to provide certain disclosures about the change in accounting principle, including the nature of and reason for the change, the transition method, a description of the prior-period information that has been retrospectively adjusted and the effect of the change on the financial statement line items (that is, debt issuance cost asset and the debt liability). The Company plans to adopt this standard beginning February 1, 2016. Adoption of this standard will result in the reclassification of $15,058 in deferred financing costs at January 31, 2016 from assets to a deduction from the related debt liability. In November 2015, the FASB issued Accounting Standards Update No. 2015-17 “Income Taxes: Balance Sheet Classification of Deferred Taxes (“ASU 2015-17”). ASU 2015-17 eliminates the requirement to bifurcate deferred taxes between current and non-current on the balance sheet and requires that deferred tax liabilities and assets be classified as noncurrent on the balance sheet. ASU 2015-17 is effective for public entities in fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. The amendments for ASU-2015-17 can be applied retrospectively or prospectively and early adoption is permitted. The adoption of this standard is not expected to have a material impact for any period presented. In February 2016, FASB issued ASU 2016-02, Leases

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2016
Revenue from External Customers by Geographic Areas [Table Text Block]	2016 2015 United States $ 1,090,024 $ 343,769 Canada 299,390 213,443 $ 1,389,414 $ 557,212
Long-lived Assets by Geographic Areas [Table Text Block]	2016 2015 Equipment Intangible assets Equipment Intangible assets United States $ 7,091 $ 53,738 $ 12,688 $ 14,211 Canada 6,124 19,357 8,453 29,945 $ 13,215 $ 73,095 $ 21,141 $ 44,156
Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block]	Years Furniture and equipment 5 Computer equipment 2
Schedule of Fair Value of Convertible Promissory Notes Using the Black Scholes Option Pricing Model [Table Text Block]	2016 2015 Risk-free interest rate 0.33% 0.61% Expected life (years) 0.67 2.34 Expected volatility (1) 91.47% 147.42% Stock price $2.79 $4.80 Dividend yields 0.00% 0.00%
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	2016 2015 Numerator Net loss $ (19,063,399 ) $ (21,078,265 ) Denominator Weighted average shares outstanding 1,881,901 903,659 Effect of dilutive securities Warrants and options - - Convertible debt - - Diluted weighted average shares outstanding 1,881,901 903,659 Basic net loss per share $ (10.13 ) $ (23.33 ) Diluted net loss per share $ (10.13 ) $ (23.33 ) Anti-dilutive securities not included in diluted loss per share relating to: Warrants and options outstanding 3,836,472 3,423,399 Convertible debt 60,000 2,449,944 3,896,472 5,873,343

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Inventory, Current [Table Text Block]	2016 2015 Finished goods $ 1,308,442 $ 362,226 Raw material 3,007 - 1,311,449 362,226 Less: allowance for obsolete inventory (390,000 ) (179,000 ) Total inventory $ 921,449 $ 183,226

Equipment (Tables)

Equipment (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Property, Plant and Equipment [Table Text Block]	2016 2015 Furniture & equipment $ 10,250 $ 11,630 Computer equipment 26,082 20,963 36,332 32,593 Less: Accumulated depreciation (23,117 ) (11,452 ) $ 13,215 $ 21,141
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Useful life 2016 2015 (Years) Trade Names/Trademarks $ 73,095 $ 39,781 Indefinite Website 49,512 49,512 2 122,607 89,293 Less: accumulated amortization (49,512 ) (45,137 ) $ 73,095 $ 44,156

Convertible Promissory Notes 25

Convertible Promissory Notes Payable (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Convertible Promissory Notes Payable [Table Text Block]	January 31, 2016 January 31, 2015 Senior Secured Convertible Debentures, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to First and Second Kalamalka Amendment Agreement, due June 10, 2017 (i). $ - $ 7,169,832 First and Second Kalamalka Amendment Agreement, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to Senior Secured Convertible Debentures due October 1, 2016 (Note 9 (i)) (ii)) 600,000 600,000 Less: debt discounts - (7,163,982 ) 600,000 605,850 Less: current portion (600,000 ) - $ - $ 605,850
At Issuance [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	June 10, 2014 July 8, 2014 Risk-free interest rate 1.71% 1.70% Expected life (years) 5.00 5.00 Expected volatility (1) 147.39% 147.39% Stock price at issuance $6.00 $6.50 Dividend yields 0.00% 0.00%
Agents Warrants and Lender Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Risk-free interest rate 0.66% Expected life (years) 2.50 Expected volatility (1) 141.72% Stock price $9.20 Dividend yields 0.00%
New Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Risk-free interest rate 1.71% Expected life (years) 5.00 Expected volatility (1) 149.76% Stock price at date of issuance $9.20 Dividend yields 0.00%
Exchanged Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Existing Exchanged Warrants Warrants Risk-free interest rate 0.96% 1.71% Expected life (years) 3.52 5.00 Expected volatility (1) 146.70% 149.76% Stock price at date of issuance $9.20 $9.20 Dividend yields 0.00% 0.00%

Derivative financial instrume26

Derivative financial instruments (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Derivative Instruments [Table Text Block]	2016 2015 Embedded conversion features $ - $ 1,769,100 Warrants - 2,030,850 $ - $ 3,799,950
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	2016 2015 Derivative financial instruments, beginning of the year $ 3,799,950 $ 241,618 Fair value of warrants and embedded conversion features at commitment dates - 20,890,900 Fair value mark to market adjustments (708,900 ) (1,921,568 ) Extinguishment of derivative liability upon extinguishment of host contract - (240,000 ) Reclassification of derivative liability upon change in triggering events (3,091,050 ) (15,171,000 ) Derivative financial instruments, end of the year $ - $ 3,799,950
Schedule of Assumptions used for Fair Value of Derivative Liabilities [Table Text Block]	Reclassification January 31, Date 2015 Risk-free interest rate 0.89% 0.92% Expected life (years) 3.17 3.42 Expected volatility (1) 115.02% 136.25% Stock price $4.40 $4.80 Dividend yields 0.00% 0.00%

Stockholders Equity (Tables)

Stockholders Equity (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Weighted Average Number Average Grant Date of Options Exercise Price Fair Value Outstanding at February 1, 2014 75,125 $ 13.60 Expired (7,125 ) $ 10.00 Granted 1,726,875 $ 5.20 $ 8.40 Outstanding at January 31, 2015 1,794,875 $ 5.48 $ 8.40 Expired (22,250 ) $ 22.81 Forfeited (3,750 ) $ 4.48 Granted 422,399 $ 4.48 $ 4.15 Outstanding at January 31, 2016 2,191,274 $ 5.12 Exercisable at January 31, 2016 1,238,402 $ 5.26
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Exercise Expiry Number Number Price Date Vested 1,375 $10.00 April 1, 2016 1,375 15,000 $10.00 October 9, 2017 15,000 1,250 $10.00 February 1, 2018 1,250 3,750 $10.00 May 1, 2018 3,750 2,000 $10.00 April 1, 2019 2,000 25,000 $10.00 July 30, 2022 25,000 1,699,250 $5.12 June 6, 2024 1,068,813 25,000 $6.00 June 10, 2024 15,000 37,500 $4.48 February 3, 2025 - 37,500 $4.48 February 25, 2025 - 6,250 $4.80 July 6, 2025 - 337,399 $4.40 August 18, 2025 106,214 2,191,274 1,238,402
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2016 2015 Expected term of stock option (years) (1) 6.43 6.54 Expected volatility (2) 124.33% 110.84% Stock price at date of issuance $ 4.71 $ 5.20 Risk-free interest rate 1.81% 2.07% Dividend yields 0.00% 0.00%
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Exercise Expiry Number Price Date 6,250 $4.00 November 14, 2016 6,250 $4.00 November 26, 2016 5,688 $4.00 December 24, 2016 12,451 $10.00 August 10, 2017 3,750 $10.00 August 10, 2018 60,001 $6.00 April 4, 2019 555,968 $6.00 June 10, 2019 155,052 $3.00 June 10, 2019 168,883 $6.00 July 8, 2019 29,343 $3.00 July 8, 2019 24,625 $8.00 October 23, 2019 137,180 $4.80 December 23, 2020 365,688 $4.80 June 15, 2022 36,569 (1) $4.80 June 15, 2022 15,000 $4.80 July 6, 2022 62,500 $5.11 September 1, 2022 1,645,198
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Weighted Number of Average Warrants Exercise Price Outstanding at February 1, 2014 94,262 $ 16.00 Cancelled (15,000 ) $ 20.00 Issued 1,579,581 $ 5.60 Expired (30,262 ) $ 25.60 Outstanding at January 31, 2015 1,628,581 $ 5.74 Issued 616,937 $ 4.83 Exercised (585,709 ) $ 6.00 Expired (14,611 ) $ 9.82 Outstanding at January 31, 2016 1,645,198 $ 5.27

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	January 31, 2016 2015 34% 34% Loss for the year $ (19,063,399 ) $ (21,078,265 ) Expected income tax recovery (6,482,000 ) (7,167,000 ) Non-deductible other expenses 21,000 483,000 Non-deductible accretion and financing fees 2,467,000 541,500 Non-deductible derivative expense - 4,090,000 Non-deductible derivative mark-to-market adjustments (241,000 ) (653,000 ) Effect of foreign exchange and other adjustments (4,000 ) (1,000 ) True up to prior years’ tax provision (120,600 ) - Change in valuation allowance 4,359,600 2,706,000 Total income tax expense $ - $ -
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	January 31, 2016 2015 Temporary differences relating to: Net operating loss carry forwards $ 5,968,100 $ 3,627,000 Equipment and intangible assets 25,700 12,800 Stock based compensation 3,457,200 1,451,600 9,451,000 5,091,400 Valuation allowance (9,451,000 ) (5,091,400 ) Net deferred taxes $ - $ -

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Jan. 31, 2016
Schedule of Minimum Royalty Payments [Table Text Block]	Year ending January 31, Amount 2017 $ 312,500 2018 350,000 2019 350,000 2020 262,500 $ 1,275,000
Schedule of Strategic Consulting and Collaboration Agreement Payments [Table Text Block]	Year ending January 31, Amount 2017 $ 60,000 2018 175,000 2019 235,000 2020 20,000 $ 490,000

Nature of Business (Narrative)

Nature of Business (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016shares
Nature Of Business 1	450,000,000
Nature Of Business 2	11,250,000
Nature Of Business 3	53,278,818
Nature Of Business 4	1,331,977

Ability to Continue as a Goin31

Ability to Continue as a Going Concern (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Ability To Continue As A Going Concern 1	$ 19,063,399
Ability To Continue As A Going Concern 2	$ 46,381,080

Summary of Significant Accoun32

Summary of Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)mo
Summary Of Significant Accounting Policies 1	50.00%
Summary Of Significant Accounting Policies 2	$ 10,440
Summary Of Significant Accounting Policies 3	25,930
Summary Of Significant Accounting Policies 4	404,092
Summary Of Significant Accounting Policies 5	91,000
Summary Of Significant Accounting Policies 6	201,198
Summary Of Significant Accounting Policies 7	38,278
Summary Of Significant Accounting Policies 8	567,776
Summary Of Significant Accounting Policies 9	$ 15,476,300
Summary Of Significant Accounting Policies 10	18.00%
Summary Of Significant Accounting Policies 11 | mo	12
Summary Of Significant Accounting Policies 12	$ 15,058

Inventory (Narrative) (Details)

Inventory (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Inventory 1	$ 390,000
Inventory 2	$ 179,000

Equipment (Narrative) (Details)

Equipment (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Equipment 1	$ 13,047
Equipment 2	6,588
Equipment 3	4,375
Equipment 4	$ 23,270

Related Party Transactions an35

Related Party Transactions and Balances (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)$ / shares$ / yrshares
Related Party Transactions And Balances 1	$ 43,089
Related Party Transactions And Balances 2	17,060
Related Party Transactions And Balances 3	0
Related Party Transactions And Balances 4	978,779
Related Party Transactions And Balances 5	0
Related Party Transactions And Balances 6	8,247
Related Party Transactions And Balances 7	0
Related Party Transactions And Balances 8	791
Related Party Transactions And Balances 9	0
Related Party Transactions And Balances 10	58,400
Related Party Transactions And Balances 11	5,334,266
Related Party Transactions And Balances 12	3,147,400
Related Party Transactions And Balances 13	282,277
Related Party Transactions And Balances 14	132,500
Related Party Transactions And Balances 15	90,777
Related Party Transactions And Balances 16	$ 0
Related Party Transactions And Balances 17 | shares	1,875
Related Party Transactions And Balances 18 | shares	7,500
Related Party Transactions And Balances 19	$ 0
Related Party Transactions And Balances 20	$ 24,900
Related Party Transactions And Balances 21 | $ / yr	400,000
Related Party Transactions And Balances 22 | shares	1,428,750
Related Party Transactions And Balances 23	20.00%
Related Party Transactions And Balances 24 | $ / shares	$ 5.12
Related Party Transactions And Balances 25 | shares	2,500
Related Party Transactions And Balances 26	$ 15,000
Related Party Transactions And Balances 27 | shares	2,500
Related Party Transactions And Balances 28 | $ / shares	$ 4.80
Related Party Transactions And Balances 29	$ 170,369
Related Party Transactions And Balances 30	170,369
Related Party Transactions And Balances 31	16,640
Related Party Transactions And Balances 32	10,400
Related Party Transactions And Balances 33	266,664
Related Party Transactions And Balances 34	$ 0
Related Party Transactions And Balances 35	3.00%
Related Party Transactions And Balances 36 | $ / yr	200,000
Related Party Transactions And Balances 37 | shares	70,000
Related Party Transactions And Balances 38 | $ / shares	$ 5.12
Related Party Transactions And Balances 39	$ 100,000
Related Party Transactions And Balances 40 | $ / yr	175,000
Related Party Transactions And Balances 41 | shares	92,500
Related Party Transactions And Balances 42 | $ / shares	$ 5.12

Factoring Line of Credit (Narra

Factoring Line of Credit (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Factoring Line Of Credit 1	$ 750,000
Factoring Line Of Credit 2	80.00%
Factoring Line Of Credit 3	60.00%
Factoring Line Of Credit 4	100.00%
Factoring Line Of Credit 5	$ 500,000
Factoring Line Of Credit 6	0.90%
Factoring Line Of Credit 7	5.50%
Factoring Line Of Credit 8	2.00%
Factoring Line Of Credit 9	3.25%
Factoring Line Of Credit 10	5.50%
Factoring Line Of Credit 11	1.00%
Factoring Line Of Credit 12	$ 35,582
Factoring Line Of Credit 13	0
Factoring Line Of Credit 14	527,711
Factoring Line Of Credit 15	$ 0

Promissory Notes Payable (Narra

Promissory Notes Payable (Narrative) (Details) - 12 months ended Jan. 31, 2016	USD ($)shares	CADshares
Promissory Notes Payable 1 | CAD		CAD 28,750
Promissory Notes Payable 2	$ 24,467
Promissory Notes Payable 3 | CAD		CAD 25,000
Promissory Notes Payable 4	15.00%	15.00%
Promissory Notes Payable 5	$ 3,670
Promissory Notes Payable 6 | CAD		CAD 3,750
Promissory Notes Payable 7	3,450
Promissory Notes Payable 8 | CAD		3,750
Promissory Notes Payable 9	3,450
Promissory Notes Payable 10 | CAD		CAD 3,750
Promissory Notes Payable 11	3,280
Promissory Notes Payable 12	$ 0
Promissory Notes Payable 13	6.00%	6.00%
Promissory Notes Payable 14	$ 1,083,797
Promissory Notes Payable 15	878,704
Promissory Notes Payable 16	76,388
Promissory Notes Payable 17	128,705
Promissory Notes Payable 18	$ 1,083,797
Promissory Notes Payable 19	6.00%	6.00%
Promissory Notes Payable 20	$ 10,362
Promissory Notes Payable 21	90.00%	90.00%
Promissory Notes Payable 22	$ 121,573
Promissory Notes Payable 23	89,849
Promissory Notes Payable 24	0
Promissory Notes Payable 25	10,372
Promissory Notes Payable 26	0
Promissory Notes Payable 27	89,849
Promissory Notes Payable 28	75,000
Promissory Notes Payable 29	$ 75,000
Promissory Notes Payable 30	10.00%	10.00%
Promissory Notes Payable 31 | shares	19,922	19,922
Promissory Notes Payable 32	$ 4,685
Promissory Notes Payable 33	119,528
Promissory Notes Payable 34	199,213
Promissory Notes Payable 35 | CAD		CAD 109,212
Promissory Notes Payable 36	0
Promissory Notes Payable 37	16,755
Promissory Notes Payable 38	0
Promissory Notes Payable 39	935
Promissory Notes Payable 40	309,062
Promissory Notes Payable 41	250,000
Promissory Notes Payable 42	$ 37,500
Promissory Notes Payable 43	15.00%	15.00%
Promissory Notes Payable 44	$ 21,562
Promissory Notes Payable 45	41,667
Promissory Notes Payable 46	63,229
Promissory Notes Payable 47	0
Promissory Notes Payable 48	$ 33,972

Convertible Promissory Notes 38

Convertible Promissory Notes Payable (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)d$ / sharesshares
Convertible Promissory Notes Payable 1	$ 7,309,832
Convertible Promissory Notes Payable 2 | shares	292
Convertible Promissory Notes Payable 3	$ 25,000
Convertible Promissory Notes Payable 4	6.00%
Convertible Promissory Notes Payable 5	$ 25,000
Convertible Promissory Notes Payable 6	4,167
Convertible Promissory Notes Payable 7 | $ / shares	$ 6
Convertible Promissory Notes Payable 8	$ 7,309,832
Convertible Promissory Notes Payable 9	$ 6,094,100
Convertible Promissory Notes Payable 10	6.00%
Convertible Promissory Notes Payable 11	$ 1,094,159
Convertible Promissory Notes Payable 12	$ 1,215,732
Convertible Promissory Notes Payable 13	90.00%
Convertible Promissory Notes Payable 14	6.00%
Convertible Promissory Notes Payable 15	101,239
Convertible Promissory Notes Payable 16	48,750
Convertible Promissory Notes Payable 17	$ 303,717
Convertible Promissory Notes Payable 18	146,245
Convertible Promissory Notes Payable 19	463,679
Convertible Promissory Notes Payable 20	$ 274,823
Convertible Promissory Notes Payable 21 | $ / shares	$ 3
Convertible Promissory Notes Payable 22	$ 10,000,000
Convertible Promissory Notes Payable 23	50,000,000
Convertible Promissory Notes Payable 24	$ 15
Convertible Promissory Notes Payable 25	20
Convertible Promissory Notes Payable 26	1,218,308
Convertible Promissory Notes Payable 27 | shares	1,218,308
Convertible Promissory Notes Payable 28 | $ / shares	$ 6
Convertible Promissory Notes Payable 29 | $ / shares	$ 16
Convertible Promissory Notes Payable 30	20
Convertible Promissory Notes Payable 31 | d	30
Convertible Promissory Notes Payable 32 | shares	2,500,000
Convertible Promissory Notes Payable 33	$ 19,338,215
Convertible Promissory Notes Payable 34	7,309,832
Convertible Promissory Notes Payable 35	12,028,383
Convertible Promissory Notes Payable 36	59,935
Convertible Promissory Notes Payable 37	5,895
Convertible Promissory Notes Payable 38	2,021,213
Convertible Promissory Notes Payable 39	$ 468,513
Convertible Promissory Notes Payable 40	8.00%
Convertible Promissory Notes Payable 41 | shares	276,592
Convertible Promissory Notes Payable 42	8.00%
Convertible Promissory Notes Payable 43	100.00%
Convertible Promissory Notes Payable 44	$ 1,552,700
Convertible Promissory Notes Payable 45	100.00%
Convertible Promissory Notes Payable 46 | shares	1,039,276
Convertible Promissory Notes Payable 47 | shares	60,000
Convertible Promissory Notes Payable 48	979,276
Convertible Promissory Notes Payable 49	79,025
Convertible Promissory Notes Payable 50 | shares	46,667
Convertible Promissory Notes Payable 51	77,789
Convertible Promissory Notes Payable 52 | shares	46,667
Convertible Promissory Notes Payable 53	$ 233,358
Convertible Promissory Notes Payable 54	$ 140,000
Convertible Promissory Notes Payable 55	1,236
Convertible Promissory Notes Payable 56 | shares	0
Convertible Promissory Notes Payable 57	$ 3,706
Convertible Promissory Notes Payable 58	0
Convertible Promissory Notes Payable 59	232,918
Convertible Promissory Notes Payable 60	139,896
Convertible Promissory Notes Payable 61	8,000,000
Convertible Promissory Notes Payable 62	6,936,450
Convertible Promissory Notes Payable 63	37,805
Convertible Promissory Notes Payable 64	$ 208,093
Convertible Promissory Notes Payable 65 | shares	2,394,116
Convertible Promissory Notes Payable 66 | $ / shares	$ 3
Convertible Promissory Notes Payable 67	20
Convertible Promissory Notes Payable 68	$ 6,871,129
Convertible Promissory Notes Payable 69	$ 6,936,450
Convertible Promissory Notes Payable 70 | shares	2,312,150
Convertible Promissory Notes Payable 71 | shares	81,966
Convertible Promissory Notes Payable 72	$ 37,805
Convertible Promissory Notes Payable 73	208,093
Convertible Promissory Notes Payable 74	311,468
Convertible Promissory Notes Payable 75	$ 800,000
Convertible Promissory Notes Payable 76	12.00%
Convertible Promissory Notes Payable 77 | $ / shares	$ 30
Convertible Promissory Notes Payable 78	$ 300,000
Convertible Promissory Notes Payable 79	0
Convertible Promissory Notes Payable 80	5,587
Convertible Promissory Notes Payable 81	0
Convertible Promissory Notes Payable 82	18,300
Convertible Promissory Notes Payable 83	$ 600,000
Convertible Promissory Notes Payable 84	6.00%
Convertible Promissory Notes Payable 85	$ 400,000
Convertible Promissory Notes Payable 86 | $ / shares	$ 20
Convertible Promissory Notes Payable 87 | $ / shares	$ 10
Convertible Promissory Notes Payable 88	12,500
Convertible Promissory Notes Payable 89	$ 20
Convertible Promissory Notes Payable 90	2,500
Convertible Promissory Notes Payable 91	$ 20
Convertible Promissory Notes Payable 92	15,000
Convertible Promissory Notes Payable 93	45,000
Convertible Promissory Notes Payable 94 | $ / shares	$ 6
Convertible Promissory Notes Payable 95 | $ / shares	$ 16
Convertible Promissory Notes Payable 96	20
Convertible Promissory Notes Payable 97 | d	30
Convertible Promissory Notes Payable 98	$ 697,400
Convertible Promissory Notes Payable 99	1,273,800
Convertible Promissory Notes Payable 100	576,400
Convertible Promissory Notes Payable 101	384,100
Convertible Promissory Notes Payable 102	23,300
Convertible Promissory Notes Payable 103	36,993
Convertible Promissory Notes Payable 104	28,364
Convertible Promissory Notes Payable 105	23,043
Convertible Promissory Notes Payable 106	100,000
Convertible Promissory Notes Payable 107	$ 1,868
Convertible Promissory Notes Payable 108	25,467
Convertible Promissory Notes Payable 109 | $ / shares	$ 4
Convertible Promissory Notes Payable 110	$ 187,438
Convertible Promissory Notes Payable 111	289,306
Convertible Promissory Notes Payable 112	124,444
Convertible Promissory Notes Payable 113	$ 175,000
Convertible Promissory Notes Payable 114	8,250
Convertible Promissory Notes Payable 115	$ 10.60
Convertible Promissory Notes Payable 116	60.00%
Convertible Promissory Notes Payable 117 | d	25
Convertible Promissory Notes Payable 118	$ 38,405
Convertible Promissory Notes Payable 119	217,240
Convertible Promissory Notes Payable 120	3,735
Convertible Promissory Notes Payable 121	120,709
Convertible Promissory Notes Payable 122	175,100
Convertible Promissory Notes Payable 123	42,240
Convertible Promissory Notes Payable 124	0
Convertible Promissory Notes Payable 125	2,065
Convertible Promissory Notes Payable 126	133,500
Convertible Promissory Notes Payable 127	189,640
Convertible Promissory Notes Payable 128	32,958
Convertible Promissory Notes Payable 129	64,900
Convertible Promissory Notes Payable 130	0
Convertible Promissory Notes Payable 131	20,106
Convertible Promissory Notes Payable 132	0
Convertible Promissory Notes Payable 133	17,124
Convertible Promissory Notes Payable 134	$ 128,705
Convertible Promissory Notes Payable 135	6.00%
Convertible Promissory Notes Payable 136	$ 0
Convertible Promissory Notes Payable 137	7,754
Convertible Promissory Notes Payable 138	0
Convertible Promissory Notes Payable 139	$ 4,857

Derivative financial instrume39

Derivative financial instruments (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Derivative Financial Instruments 1	2,500,000
Derivative Financial Instruments 2	11,250,000
Derivative Financial Instruments 3	$ 708,900
Derivative Financial Instruments 4	$ 1,921,568

Stockholders Equity (Narrative)

Stockholders Equity (Narrative) (Details) - 12 months ended Jan. 31, 2016	USD ($)yr$ / sharesshares	CADyrshares
Stockholders Equity 1 | shares	450,000,000	450,000,000
Stockholders Equity 2 | shares	11,250,000	11,250,000
Stockholders Equity 3 | shares	53,278,818	53,278,818
Stockholders Equity 4 | shares	1,331,977	1,331,977
Stockholders Equity 5 | shares	11,250,000	11,250,000
Stockholders Equity 6	$ 0.001
Stockholders Equity 7 | shares	2,500	2,500
Stockholders Equity 8 | $ / shares	$ 4.80
Stockholders Equity 9 | shares	205,248	205,248
Stockholders Equity 10 | $ / shares	$ 4
Stockholders Equity 11	$ 821,000
Stockholders Equity 12	6
Stockholders Equity 13	$ 4
Stockholders Equity 14	140,249	140,249
Stockholders Equity 15	$ 560,996
Stockholders Equity 16	$ 32,800
Stockholders Equity 17	1.33%	1.33%
Stockholders Equity 18 | yr	3.94	3.94
Stockholders Equity 19	139.54%	139.54%
Stockholders Equity 20	0.00%	0.00%
Stockholders Equity 21	$ 6
Stockholders Equity 22	$ 4
Stockholders Equity 23 | shares	380,461	380,461
Stockholders Equity 24	$ 1,521,829
Stockholders Equity 25	91,422
Stockholders Equity 26	$ 63,000
Stockholders Equity 27	1.26%	1.26%
Stockholders Equity 28 | yr	3.86	3.86
Stockholders Equity 29	138.81%	138.81%
Stockholders Equity 30	0.00%	0.00%
Stockholders Equity 31 | shares	1,875,000	1,875,000
Stockholders Equity 32 | $ / shares	$ 4
Stockholders Equity 33	$ 7,500,000
Stockholders Equity 34	$ 623,720
Stockholders Equity 35	8.00%	8.00%
Stockholders Equity 36	$ 548,720
Stockholders Equity 37	8.00%	8.00%
Stockholders Equity 38	137,180	137,180
Stockholders Equity 39	$ 75,000
Stockholders Equity 40 | shares	45,388	45,388
Stockholders Equity 41	$ 180,703
Stockholders Equity 42	$ 5,703
Stockholders Equity 43	8,250	8,250
Stockholders Equity 44	$ 124,444
Stockholders Equity 45	1,505	1,505
Stockholders Equity 46	$ 4,605
Stockholders Equity 47 | CAD		CAD 5,000
Stockholders Equity 48	3,945
Stockholders Equity 49	$ 8,550
Stockholders Equity 50	5,625	5,625
Stockholders Equity 51 | shares	2,750,000	2,750,000
Stockholders Equity 52	607,101	607,101
Stockholders Equity 53 | shares	1,025,750	1,025,750
Stockholders Equity 54	$ 0
Stockholders Equity 55	0
Stockholders Equity 56	0
Stockholders Equity 57	0
Stockholders Equity 58	5,374,465
Stockholders Equity 59	3,318,241
Stockholders Equity 60	$ 7,881,830
Stockholders Equity 61	110	110
Stockholders Equity 62	1,645,198	1,645,198
Stockholders Equity 63 | shares	479,756	479,756
Stockholders Equity 64 | $ / shares	$ 4.84
Stockholders Equity 65	$ 4.67
Stockholders Equity 66	$ 2,239,000
Stockholders Equity 67 | yr	7	7
Stockholders Equity 68	158.04%	158.04%
Stockholders Equity 69	0.00%	0.00%
Stockholders Equity 70	2.09%	2.09%
Stockholders Equity 71	$ 257,802
Stockholders Equity 72	0
Stockholders Equity 73	$ 168,500
Stockholders Equity 74 | yr	7	7
Stockholders Equity 75	153.00%	153.00%
Stockholders Equity 76	0.00%	0.00%
Stockholders Equity 77	2.11%	2.11%

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Income Taxes 1	$ 4,359,600
Income Taxes 2	2,706,000
Income Taxes 3	5,066,000
Income Taxes 4	1,800,000
Income Taxes 5	17,483,000
Income Taxes 6	$ 10,666,000

Customer Concentrations (Narrat

Customer Concentrations (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Customer Concentrations 1	41.00%
Customer Concentrations 2	28.00%
Customer Concentrations 3	$ 73,347
Customer Concentrations 4	$ 2,755

Commitments (Narrative) (Detail

Commitments (Narrative) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)mo
Commitments 1	$ 50,000
Commitments 2	10.00%
Commitments 3	$ 75,000
Commitments 4	0
Commitments 5	10,000
Commitments 6	$ 20,000
Commitments 7 | mo	6

Revenue from External Customers

Revenue from External Customers by Geographic Areas (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 1	$ 1,090,024
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 2	343,769
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 3	299,390
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 4	213,443
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 5	1,389,414
Summary Of Significant Accounting Policies Revenue From External Customers By Geographic Areas 6	$ 557,212

Long-lived Assets by Geographic

Long-lived Assets by Geographic Areas (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 1	$ 7,091
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 2	53,738
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 3	12,688
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 4	14,211
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 5	6,124
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 6	19,357
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 7	8,453
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 8	29,945
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 9	13,215
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 10	73,095
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 11	21,141
Summary Of Significant Accounting Policies Long-lived Assets By Geographic Areas 12	$ 44,156

Schedule of Estimated Useful Li

Schedule of Estimated Useful Lives of Property and Equipment (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Summary Of Significant Accounting Policies Schedule Of Estimated Useful Lives Of Property And Equipment [table Text Block] 1	$ 5
Summary Of Significant Accounting Policies Schedule Of Estimated Useful Lives Of Property And Equipment [table Text Block] 2	$ 2

Schedule of Fair Value of Conve

Schedule of Fair Value of Convertible Promissory Notes Using the Black Scholes Option Pricing Model (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 1	0.33%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 2	0.61%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 3	0.67
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 4	2.34
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 5	91.47%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 6	147.42%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 7	$ 2.79
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 8	$ 4.80
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 9	0.00%
Summary Of Significant Accounting Policies Schedule Of Fair Value Of Convertible Promissory Notes Using The Black Scholes Option Pricing Model 10	0.00%

Schedule of Earnings Per Share,

Schedule of Earnings Per Share, Basic and Diluted (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 1	$ (19,063,399)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 2	(21,078,265)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 3	1,881,901
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 4	903,659
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 5	0
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 6	0
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 7	0
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 8	0
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 9	1,881,901
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 10	$ 903,659
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 11	(10.13)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 12	(23.33)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 13	(10.13)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 14	(23.33)
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 15	$ 3,836,472
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 16	3,423,399
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 17	60,000
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 18	2,449,944
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 19	3,896,472
Summary Of Significant Accounting Policies Schedule Of Earnings Per Share, Basic And Diluted 20	$ 5,873,343

Schedule of Inventory, Current

Schedule of Inventory, Current (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Inventory Schedule Of Inventory, Current 1	$ 1,308,442
Inventory Schedule Of Inventory, Current 2	362,226
Inventory Schedule Of Inventory, Current 3	3,007
Inventory Schedule Of Inventory, Current 4	0
Inventory Schedule Of Inventory, Current 5	1,311,449
Inventory Schedule Of Inventory, Current 6	362,226
Inventory Schedule Of Inventory, Current 7	(390,000)
Inventory Schedule Of Inventory, Current 8	(179,000)
Inventory Schedule Of Inventory, Current 9	921,449
Inventory Schedule Of Inventory, Current 10	$ 183,226

Schedule of Property, Plant and

Schedule of Property, Plant and Equipment (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Equipment Schedule Of Property, Plant And Equipment 1	$ 10,250
Equipment Schedule Of Property, Plant And Equipment 2	11,630
Equipment Schedule Of Property, Plant And Equipment 3	26,082
Equipment Schedule Of Property, Plant And Equipment 4	20,963
Equipment Schedule Of Property, Plant And Equipment 5	36,332
Equipment Schedule Of Property, Plant And Equipment 6	32,593
Equipment Schedule Of Property, Plant And Equipment 7	(23,117)
Equipment Schedule Of Property, Plant And Equipment 8	(11,452)
Equipment Schedule Of Property, Plant And Equipment 9	13,215
Equipment Schedule Of Property, Plant And Equipment 10	$ 21,141

Schedule of Acquired Finite-Liv

Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 1	$ 73,095
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 2	39,781
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 3	49,512
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 4	49,512
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 5	2
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 6	122,607
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 7	89,293
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 8	(49,512)
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 9	(45,137)
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 10	73,095
Equipment Schedule Of Acquired Finite-lived Intangible Assets By Major Class 11	$ 44,156

Schedule of Convertible Promiss

Schedule of Convertible Promissory Notes Payable (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 1	6.00%
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 2	$ 0
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 3	$ 7,169,832
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 4	6.00%
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 5	$ 600,000
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 6	600,000
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 7	0
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 8	(7,163,982)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 9	600,000
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 10	605,850
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 11	(600,000)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 12	0
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 13	0
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 14	$ 605,850

Schedule of Fair Value of the A

Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
At Issuance [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	1.70%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	147.39%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 6	147.39%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 7	$ 6
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 8	$ 6.50
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 9	0.00%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 10	0.00%
Agents Warrants and Lender Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.66%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	2.50
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	141.72%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	$ 9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
New Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	149.76%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	$ 9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Exchanged Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.96%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	3.52
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	146.70%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 6	149.76%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 7	$ 9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 8	$ 9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 9	0.00%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 10	0.00%

Schedule of Derivative Instrume

Schedule of Derivative Instruments (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Derivative Financial Instruments Schedule Of Derivative Instruments 1	$ 0
Derivative Financial Instruments Schedule Of Derivative Instruments 2	1,769,100
Derivative Financial Instruments Schedule Of Derivative Instruments 3	0
Derivative Financial Instruments Schedule Of Derivative Instruments 4	2,030,850
Derivative Financial Instruments Schedule Of Derivative Instruments 5	0
Derivative Financial Instruments Schedule Of Derivative Instruments 6	$ 3,799,950

Schedule of Derivative Liabilit

Schedule of Derivative Liabilities at Fair Value (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 1	$ 3,799,950
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 2	241,618
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 3	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 4	20,890,900
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 5	(708,900)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 6	(1,921,568)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 7	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 8	(240,000)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 9	(3,091,050)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 10	(15,171,000)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 11	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 12	$ 3,799,950

Schedule of Assumptions used fo

Schedule of Assumptions used for Fair Value of Derivative Liabilities (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 1	0.89%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 2	0.92%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 3	3.17
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 4	3.42
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 5	115.02%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 6	136.25%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 7	$ 4.40
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 8	$ 4.80
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 9	0.00%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 10	0.00%

Schedule of Share-based Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 1	$ 75,125
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 2	13.60
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 3	$ (7,125)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 4	10
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 5	$ 1,726,875
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 6	5.20
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 7	8.40
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 8	$ 1,794,875
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 9	5.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 10	8.40
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 11	$ (22,250)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 12	22.81
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 13	$ (3,750)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 14	4.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 15	$ 422,399
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 16	4.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 17	4.15
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 18	$ 2,191,274
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 19	5.12
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 20	$ 1,238,402
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 21	5.26

Disclosure of Share-based Compe

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1	$ 1,375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3	1,375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4	15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6	15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7	1,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9	1,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10	3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12	3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13	2,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15	2,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16	25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18	25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19	1,699,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20	5.12
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21	1,068,813
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22	25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23	6
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24	15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25	37,500
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26	4.48
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27	0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28	37,500
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29	4.48
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30	0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31	6,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32	4.80
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33	0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34	337,399
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35	4.40
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36	106,214
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37	2,191,274
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38	$ 1,238,402

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	12 Months Ended
	Jan. 31, 2016
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	6.43
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	6.54
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	124.33%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	110.84%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	4.71
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	5.20
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	1.81%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	2.07%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9	0.00%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 10	0.00%

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 1	$ 6,250
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 2	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 3	6,250
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 4	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 5	5,688
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 6	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 7	12,451
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 8	10
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 9	3,750
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 10	10
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 11	60,001
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 12	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 13	555,968
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 14	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 15	155,052
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 16	3
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 17	168,883
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 18	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 19	29,343
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 20	3
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 21	24,625
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 22	8
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 23	137,180
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 24	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 25	365,688
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 26	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 27	36,569
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 28	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 29	15,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 30	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 31	62,500
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 32	5.11
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 33	$ 1,645,198

Schedule of Stockholders' Equ61

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1	$ 94,262
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2	16
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3	$ (15,000)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4	20
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5	$ 1,579,581
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6	5.60
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7	$ (30,262)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8	25.60
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9	$ 1,628,581
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10	5.74
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11	$ 616,937
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12	4.83
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13	$ (585,709)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15	$ (14,611)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16	9.82
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17	$ 1,645,198
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18	5.27

Schedule of Components of Incom

Schedule of Components of Income Tax Expense (Benefit) (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 1	34.00%
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 2	34.00%
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 3	$ (19,063,399)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 4	(21,078,265)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 5	(6,482,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 6	(7,167,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 7	21,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 8	483,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 9	2,467,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 10	541,500
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 11	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 12	4,090,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 13	(241,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 14	(653,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 15	(4,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 16	(1,000)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 17	(120,600)
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 18	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 19	4,359,600
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 20	2,706,000
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 21	0
Income Taxes Schedule Of Components Of Income Tax Expense (benefit) 22	$ 0

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	$ 5,968,100
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	3,627,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	25,700
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	12,800
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	3,457,200
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	1,451,600
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	9,451,000
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	5,091,400
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	(9,451,000)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	(5,091,400)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	$ 0

Schedule of Minimum Royalty Pay

Schedule of Minimum Royalty Payments (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Commitments Schedule Of Minimum Royalty Payments 1	$ 312,500
Commitments Schedule Of Minimum Royalty Payments 2	350,000
Commitments Schedule Of Minimum Royalty Payments 3	350,000
Commitments Schedule Of Minimum Royalty Payments 4	262,500
Commitments Schedule Of Minimum Royalty Payments 5	$ 1,275,000

Schedule of Strategic Consultin

Schedule of Strategic Consulting and Collaboration Agreement Payments (Details)	12 Months Ended
	Jan. 31, 2016USD ($)
Commitments Schedule Of Strategic Consulting And Collaboration Agreement Payments 1	$ 60,000
Commitments Schedule Of Strategic Consulting And Collaboration Agreement Payments 2	175,000
Commitments Schedule Of Strategic Consulting And Collaboration Agreement Payments 3	235,000
Commitments Schedule Of Strategic Consulting And Collaboration Agreement Payments 4	20,000
Commitments Schedule Of Strategic Consulting And Collaboration Agreement Payments 5	$ 490,000